syndrome	score	normalized_score
PARAMYOTONIA CONGENITA OF VON EULENBURG	4.3449618999999995	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	46.03032307371902
MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	1.083334	24.93310700837216
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.0	23.01516153685951
HORNER SYNDROME, CONGENITAL	1.0	23.01516153685951
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0	23.01516153685951
ANAPLASTIC THYROID CARCINOMA	1.0	23.01516153685951
DEXTROCARDIA	1.0	23.01516153685951
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	0.91961685	21.165130354767903
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.7872689	18.119120906445694
RICHIERI COSTA-DA SILVA SYNDROME	0.70811219	16.297316439069355
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.5526316	12.71890554437313
GNE MYOPATHY	0.5473422	12.597169148940065
AURICULOCONDYLAR SYNDROME	0.5285714	12.165156154763983
RIPPLING MUSCLE DISEASE; RMD	0.5120482	11.784872037658143
RIPPLING MUSCLE DISEASE 1; RMD1	0.5120482	11.784872037658143
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.50316456	11.58041362802284
OBESITY DUE TO SIM1 DEFICIENCY	0.5	11.507580768429754
RIGID SPINE MUSCULAR DYSTROPHY 1	0.5	11.507580768429754
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	11.507580768429754
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.5	11.507580768429754
MYOPATHY AND DIABETES MELLITUS	0.475641	10.946954448553393
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.47483770000000003	10.928466369290835
MULTIPLE SYSTEM ATROPHY	0.47483770000000003	10.928466369290835
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.47483770000000003	10.928466369290835
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.45387597	10.446028767248801
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.4523813	10.411628695754501
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.4242421	9.764000462236504
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.41233770000000003	9.490018773237116
SYRINGOMYELIA, ISOLATED	0.392857	9.041667315886016
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.3544849	8.15852723587749
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.35247812	8.112340870008552
SALT-AND-PEPPER SYNDROME	0.33976266	7.819692504093075
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.33641941999999997	7.742747295436583
PIERPONT SYNDROME	0.333333	7.6717128405659905
ARNOLD-CHIARI MALFORMATION TYPE I	0.3125	7.1922379802685965
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.309524	7.123744859534903
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.2961107	6.815035593292546
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.2857143	6.575760767890738
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.2857143	6.575760767890738
INCLUSION BODY MYOSITIS	0.27503520000000004	6.329979556322463
ZEBRA BODY MYOPATHY	0.269204	6.195773546368727
NEMALINE MYOPATHY 7; NEM7	0.26785020000000004	6.164615620680128
DERMATOMYOSITIS	0.2655943	6.1126957177691255
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.265174	6.103022445375183
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.26321337	6.057898229211171
DISTAL MYOPATHY, TATEYAMA TYPE	0.2616279	6.021408381049326
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.2616279	6.021408381049326
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.2616279	6.021408381049326
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.25757610000000003	5.92815554953428
BARTH SYNDROME; BTHS	0.25699438	5.914767169765057
CHIARI MALFORMATION TYPE I	0.25537634	5.877527717791956
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.25414938	5.849289035192691
INCLUSION BODY MYOSITIS	0.25308642	5.824824839085471
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.25	5.753790384214877
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.25	5.753790384214877
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.25	5.753790384214877
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.2280223	5.24797006850624
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.225641	5.193164064338516
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.225641	5.193164064338516
STUVE-WIEDEMANN SYNDROME	0.22390778	5.1532737260596
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.2140092	4.925456308374074
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.212987	4.901930210251097
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.21228052	4.885670458928535
STÜVE-WIEDEMANN SYNDROME	0.20777868000000002	4.782059884115441
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.20649595	4.752537645957265
NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE	0.20387597000000002	4.692238383033923
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.20238130000000001	4.657838311539626
METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASEA	0.2	4.603032307371902
MUNGAN SYNDROME	0.2	4.603032307371902
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.18561915	4.272054721584556
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.18214105	4.192005688243205
LAING EARLY-ONSET DISTAL MYOPATHY	0.18174318	4.182848645922534
AL AMYLOIDOSIS	0.18150880000000003	4.177454352361526
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.1800003	4.142735981183172
DERMATOLEUKODYSTROPHY	0.179654	4.134765830742959
MULTIMINICORE MYOPATHY	0.17871520000000002	4.113159197092155
NORRIE DISEASE	0.17288435	3.978961242444957
PGM3-CDG	0.17051315	3.924387691408756
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.1702131	3.917481992189621
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17011528	3.915230649088086
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.16849799999999998	3.8780086886377534
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	3.835867927863764
MUCOLIPIDOSIS TYPE II	0.166667	3.835867927863764
CEREBROOCULONASAL SYNDROME	0.166667	3.835867927863764
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.166667	3.835867927863764
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.166667	3.835867927863764
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.166667	3.835867927863764
MIYOSHI MYOPATHY	0.166667	3.835867927863764
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.166667	3.835867927863764
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.166667	3.835867927863764
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.1666665	3.8358564202829952
WILD TYPE ATTR AMYLOIDOSIS	0.16233770000000003	3.7362283890222385
VARIANT ABETA2M AMYLOIDOSIS	0.16233770000000003	3.7362283890222385
MYOTILINOPATHY	0.16041007000000002	3.6918636731889416
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.14594342	3.3589113865417324
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.14594342	3.3589113865417324
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.14594342	3.3589113865417324
AUTOIMMUNE HYPOPARATHYROIDISM	0.14594342	3.3589113865417324
PHACE ASSOCIATION	0.14285699999999998	3.2878769316711383
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.14285699999999998	3.2878769316711383
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.14285699999999998	3.2878769316711383
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	3.2878769316711383
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.14285699999999998	3.2878769316711383
%109500 BASILAR IMPRESSION, PRIMARY	0.14285699999999998	3.2878769316711383
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.14285699999999998	3.2878769316711383
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	3.2878769316711383
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	3.2878769316711383
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.14138824000000003	3.254073183012262
POEMS SYNDROME	0.13415807	3.087669652523305
CARIBBEAN PARKINSONISM	0.133787	3.079129416531823
SCLERODERMA	0.13376090999999998	3.0785289509673257
SYSTEMIC SCLEROSIS	0.12696491	2.922117913162829
CUSHING SYNDROME	0.12696465999999998	2.9221121593724444
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.12549925	2.888385511504716
WHIPPLE DISEASE	0.12377978999999999	2.848811861848547
KALLMANN SYNDROME	0.12067368999999999	2.777324468598908
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.11783925	2.712089374132372
KENNEDY DISEASE	0.11764569999999999	2.7076347896169124
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.11718690000000001	2.6970754335038016
PLAGUE	0.11588835	2.6671890954901127
CONGENITAL MYASTHENIC SYNDROME	0.11350784	2.6124012733000033
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.11350784	2.6124012733000033
MICROSPORIDIOSIS	0.11228052000000001	2.584154305242585
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.11221465000000003	2.5826382965521524
LEPTOSPIROSIS	0.11151131	2.566450812836817
PHELAN-MCDERMID SYNDROME	0.11121057000000001	2.5595292331562223
ISOLATED SPINA BIFIDA	0.11111099999999999	2.5572376135219965
RAT-BITE FEVER	0.1093924	2.51768375690475
JUVENILE XANTHOGRANULOMA	0.10826446	2.491724035600865
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.10562342000000001	2.4309400733755577
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.10537634000000001	2.4252534872630305
ENCEPHALITIS LETHARGICA	0.10537634000000001	2.4252534872630305
AA AMYLOIDOSIS	0.10401606000000001	2.3939464233276713
LEISHMANIASIS	0.1035461	2.3831302180118086
PRADER-WILLI SYNDROME	0.10232326	2.354986357878075
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.10163077000000001	2.3390485886654155
MYXOPAPILLARY EPENDYMOMA	0.10030150000000002	2.308455224889314
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.1	2.301516153685951
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.1	2.301516153685951
NEUROFACIODIGITORENAL SYNDROME	0.1	2.301516153685951
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.1	2.301516153685951
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.1	2.301516153685951
LICHEN PLANUS PEMPHIGOIDES	0.1	2.301516153685951
ELLIS VAN CREVELD SYNDROME	0.1	2.301516153685951
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.1	2.301516153685951
WHIM SYNDROME	0.1	2.301516153685951
X-LINKED ADRENOLEUKODYSTROPHY	0.09972208000000002	2.295119779991627
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.09965114000000001	2.2934870844322024
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.09965114	2.293487084432202
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.09550402000000002	2.1980404477194617
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.09491755	2.1845427459329394
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09491755	2.1845427459329394
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.093886	2.160801456049592
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	0.09347830000000001	2.1514181746910146
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.09347830000000001	2.1514181746910146
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.09330630000000001	2.1474595669066745
TETANUS	0.0909091	2.092287621670515
PROTEUS SYNDROME	0.0909091	2.092287621670515
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.0909091	2.092287621670515
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.0909091	2.092287621670515
AGEL AMYLOIDOSIS	0.09021816	2.076385525958237
POSTPOLIOMYELITIS SYNDROME	0.08982925000000001	2.067434699484937
MENINGIOMA	0.08843441000000002	2.0353322315668643
CRANIOPHARYNGIOMA	0.08843441000000002	2.0353322315668643
LEBER HEREDITARY OPTIC NEUROPATHY	0.08830427	2.032337038444457
CONE-ROD DYSTROPHY 2	0.0879433	2.0240292555844968
PRADER-WILLI SYNDROME; PWS	0.08748268000000001	2.0134280118773886
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0873949	2.011407740997683
HADDAD SYNDROME	0.08717945	2.006449124444567
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.08641972000000002	1.988963815770169
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0853608	1.9645926009155574
LAMBERT-EATON MYASTHENIC SYNDROME	0.08441560000000001	1.942838670230918
ISOTRETINOIN-LIKE SYNDROME	0.08384615000000001	1.9297326864937532
PERRY SYNDROME	0.08333330000000001	1.9179293608995749
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.08333330000000001	1.9179293608995749
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.08333330000000001	1.9179293608995749
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.08333330000000001	1.9179293608995749
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.08333330000000001	1.9179293608995749
OBESITY-HYPOVENTILATION SYNDROME	0.08333330000000001	1.9179293608995749
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.08333330000000001	1.9179293608995749
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0825032	1.8988244753078274
FRIEDREICH ATAXIA	0.08091095000000001	1.862178584350763
CONE-ROD DYSTROPHY 10	0.0803653	1.8496203614581757
RETINITIS PUNCTATA ALBESCENS	0.0803653	1.8496203614581757
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.07827245999999999	1.801453310787374
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0779611	1.7942873100912577
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.07746487000000002	1.7828664964818226
OPTIC ATROPHY 5; OPA5	0.07692310000000001	1.770397572415998
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.07692310000000001	1.770397572415998
NEUROTROPHIC KERATOPATHY	0.07692310000000001	1.770397572415998
NELSON SYNDROME	0.07692310000000001	1.770397572415998
CENTRAL AREOLAR CHOROIDAL DYSTROPHY	0.07692310000000001	1.770397572415998
CONE-ROD DYSTROPHY 11; CORD11	0.07692310000000001	1.770397572415998
AGNATHIA-OTOCEPHALY COMPLEX	0.07638890000000001	1.7581028731230075
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.07625018	1.7549102099146143
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.07565665	1.741250021087642
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.07564100000000001	1.7408898338095904
PURE MITOCHONDRIAL MYOPATHY	0.07564100000000001	1.7408898338095904
MENKES DISEASE	0.0756038	1.7400336698004188
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.07493116	1.7245527515442658
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.07493116	1.7245527515442658
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.07388091	1.700381078140179
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0738095	1.698737565454832
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.07235072	1.6651635081080918
DOORS SYNDROME	0.07192891	1.6554554828202295
MULTIFOCAL MOTOR NEUROPATHY	0.0718105	1.65273025754265
NOCARDIOSIS	0.07176199999999999	1.651614022208112
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.07142860000000001	1.6439407673517235
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.07142860000000001	1.6439407673517235
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.07142860000000001	1.6439407673517235
ERYTHERMALGIA, PRIMARY	0.0703328	1.6187207533396326
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.07019710000000001	1.615597595919081
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.06911930000000001	1.5907918548146536
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.06708796	1.5440402365783694
OCCIPITAL HORN SYNDROME	0.06681903	1.5378507691862617
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.0666667	1.5343448696293516
MICROTIA	0.0666667	1.5343448696293516
OTOMANDIBULAR SYNDROME	0.0666667	1.5343448696293516
RETINITIS PIGMENTOSA 58	0.0666667	1.5343448696293516
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.0666667	1.5343448696293516
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0666667	1.5343448696293516
XQ21 MICRODELETION SYNDROME	0.0666667	1.5343448696293516
THALIDOMIDE EMBRYOPATHY	0.0666667	1.5343448696293516
RETINITIS PIGMENTOSA 41	0.0666667	1.5343448696293516
VACTERL WITH HYDROCEPHALUS	0.0666667	1.5343448696293516
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.0666667	1.5343448696293516
HEMIFACIAL MICROSOMIA	0.0666667	1.5343448696293516
EAR-PATELLA-SHORT STATURE SYNDROME	0.0666667	1.5343448696293516
MONOSOMY 9P	0.0666667	1.5343448696293516
MICROTIA-ANOTIA	0.0666667	1.5343448696293516
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.0666667	1.5343448696293516
RETINITIS PIGMENTOSA 75; RP75	0.0666667	1.5343448696293516
CONE-ROD DYSTROPHY 6; CORD6	0.0666667	1.5343448696293516
JUVENILE GLAUCOMA	0.0666667	1.5343448696293516
CONE-ROD DYSTROPHY 8; CORD8	0.0666667	1.5343448696293516
MUCOPOLYSACCHARIDOSIS TYPE 2	0.0666667	1.5343448696293516
2Q23.1 MICRODUPLICATION SYNDROME	0.06658237	1.5324040010569484
SCHWARTZ-JAMPEL SYNDROME	0.06631312	1.526207168813149
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0660461	1.5200616603795767
HYPERKALEMIC PERIODIC PARALYSIS	0.06594991	1.5178478319913462
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.06578941	1.5141538985646805
HELLP SYNDROME	0.06557009999999999	1.5091064434880315
CLASSICAL EHLERS-DANLOS SYNDROME	0.06531945	1.5033376932488178
CRYPTOCOCCOSIS	0.064948	1.4947887114959515
SECONDARY POLYCYTHEMIA	0.06419984000000001	1.4775696882405347
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.06321022000000001	1.4547934240804279
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.06266965000000001	1.4423521182084478
SMITH-MAGENIS SYNDROME; SMS	0.06251799000000001	1.4388616388097675
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0625	1.4384475960537193
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0625	1.4384475960537193
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.0625	1.4384475960537193
KAPOSI SARCOMA	0.0623696	1.4354464189893128
HEPATOCELLULAR CARCINOMA	0.0623696	1.4354464189893128
HUNTINGTON DISEASE-LIKE 2	0.06227178	1.4331950758877772
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.06198806	1.4266652142565395
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.061970250000000004	1.4262553142295682
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.0616279	1.418376073677424
ALG11-CDG	0.0615835	1.4173542005051876
CHRONIC GRAFT VERSUS HOST DISEASE	0.0594276	1.3677358137478721
WHITE-SUTTON SYNDROME; WHSUS	0.05940175	1.3671408718221443
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.05940175	1.3671408718221443
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.0588235	1.3538323546634554
BILATERAL POLYMICROGYRIA	0.0588235	1.3538323546634554
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0588235	1.3538323546634554
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0588235	1.3538323546634554
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	1.3538323546634554
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0588235	1.3538323546634554
PROTEUS-LIKE SYNDROME	0.0588235	1.3538323546634554
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0588235	1.3538323546634554
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.0588235	1.3538323546634554
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	1.3538323546634554
MILROY DISEASE	0.0588235	1.3538323546634554
YELLOW NAIL SYNDROME	0.0588235	1.3538323546634554
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.0588235	1.3538323546634554
RING CHROMOSOME 22 SYNDROME	0.0588235	1.3538323546634554
BUTYRYLCHOLINESTERASE	0.0588235	1.3538323546634554
KLIPPEL-TRÉNAUNAY SYNDROME	0.0588235	1.3538323546634554
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0588235	1.3538323546634554
VON WILLEBRAND DISEASE	0.0588235	1.3538323546634554
SPINOCEREBELLAR ATAXIA TYPE 40	0.0588235	1.3538323546634554
FAMILIAL MULTIPLE NEVI FLAMMEI	0.0588235	1.3538323546634554
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.0588235	1.3538323546634554
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0588235	1.3538323546634554
DERMOODONTODYSPLASIA	0.0588235	1.3538323546634554
ADULT SYNDROME	0.0588235	1.3538323546634554
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.0588235	1.3538323546634554
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.0588235	1.3538323546634554
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0588235	1.3538323546634554
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.058612920000000006	1.3489858219470237
SEVERE HEMOPHILIA A	0.05800794	1.3350621095204542
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.05687299999999999	1.3089412820858106
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.05687299999999999	1.3089412820858106
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.05687299999999999	1.3089412820858106
SPINOCEREBELLAR ATAXIA TYPE 18	0.05682582	1.3078554267645017
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.05678098	1.3068234269211891
CHOREOACANTHOCYTOSIS	0.05656368999999999	1.3018224624708448
MACHADO-JOSEPH DISEASE; MJD	0.0565476	1.3014521485217168
MYOPATHIC EHLERS-DANLOS SYNDROME	0.05650757	1.3005308516053964
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.0561777	1.2929388402692323
MYOTONIA FLUCTUANS	0.05591276	1.286841203371657
17Q21.31 MICRODUPLICATION SYNDROME	0.055555600000000004	1.2786211082771524
CROSSED POLYSYNDACTYLY	0.055555600000000004	1.2786211082771524
7P22.1 MICRODUPLICATION SYNDROME	0.055555600000000004	1.2786211082771524
WITTEVEEN-KOLK SYNDROME	0.055555600000000004	1.2786211082771524
POLAND SYNDROME	0.055555600000000004	1.2786211082771524
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.055555600000000004	1.2786211082771524
CHIME SYNDROME	0.055555600000000004	1.2786211082771524
ACROCRANIOFACIAL DYSOSTOSIS	0.055555600000000004	1.2786211082771524
3P25.3 MICRODELETION SYNDROME	0.055555600000000004	1.2786211082771524
WILDERVANCK SYNDROME	0.055555600000000004	1.2786211082771524
MYOPATHY, DISTAL, 5; MPD5	0.05520833	1.2706286331302468
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.05510620000000001	1.2682780946824876
GLYCEROL KINASE DEFICIENCY; GKD	0.05481221	1.261511867342266
USHER SYNDROME	0.05476463	1.2604168059563425
FAMILIAL DYSAUTONOMIA	0.05367905	1.2354320068951585
19P13.3 MICRODUPLICATION SYNDROME	0.05345003	1.230161074599987
INFANTILE MYOFIBROMATOSIS	0.0530914	1.221907147218023
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.211324775943375
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.0526316	1.211324775943375
LIGNEOUS CONJUNCTIVITIS	0.0526316	1.211324775943375
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	0.0526316	1.211324775943375
EHLERS-DANLOS SYNDROME, TYPE I	0.0526316	1.211324775943375
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.0526316	1.211324775943375
CONGENITAL FACTOR XIII DEFICIENCY	0.0526316	1.211324775943375
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.0526316	1.211324775943375
PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF	0.0526316	1.211324775943375
HEMOPHILIA B	0.0526316	1.211324775943375
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.0526316	1.211324775943375
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.05208702	1.1987911792736319
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.05195045	1.1956479986625432
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.05179916	1.1921660348736314
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.051490770000000005	1.1850683892072797
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.051339300000000004	1.1815822826892914
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.05083084	1.1698799936542599
MYOTONIA PERMANENS	0.05070443	1.1669706470843855
POTASSIUM-AGGRAVATED MYOTONIA	0.05070443	1.1669706470843855
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.05066283	1.166013216364452
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.05065892	1.165923227082843
SPINOCEREBELLAR ATAXIA TYPE 14	0.05	1.1507580768429755
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.05	1.1507580768429755
NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	0.05	1.1507580768429755
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.04976094	1.1452560723259737
MERRF	0.04951463	1.13958720788783
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.049404699999999996	1.1370571511800829
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.04933049	1.1353491960424325
SANDIFER SYNDROME	0.04930065	1.1346624236221727
DUBOWITZ SYNDROME	0.04930065	1.1346624236221727
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.04840435	1.1140339343366854
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.04825306	1.1105519705477742
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0478831	1.1020372813855974
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.04775458	1.0990793728248804
SPINOCEREBELLAR ATAXIA TYPE 25	0.047494360000000006	1.093090367489759
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.0473422	1.0895883805103102
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.04664286	1.073492957441123
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.046531	1.07091848147161
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.045956699999999996	1.0577008742009912
DISTAL TRISOMY 17Q	0.0454545	1.0461426600771806
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.0454545	1.0461426600771806
MERCURY POISONING	0.0454545	1.0461426600771806
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0454545	1.0461426600771806
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0454545	1.0461426600771806
DUODENAL NEUROENDOCRINE TUMOR	0.0454545	1.0461426600771806
ILEAL NEUROENDOCRINE TUMOR	0.0454545	1.0461426600771806
JEJUNAL NEUROENDOCRINE TUMOR	0.0454545	1.0461426600771806
ADENOCARCINOMA OF OVARY	0.0454545	1.0461426600771806
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.044838569999999994	1.0319669316317825
STEINERT MYOTONIC DYSTROPHY	0.0443063	1.0197166516005585
THOMSEN AND BECKER DISEASE	0.0443063	1.0197166516005585
GIANT CELL ARTERITIS	0.04394625	1.0114300426892122
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.04388092	1.0099264621860091
ADDISON DISEASE	0.04388092	1.0099264621860091
ACUTE ADRENAL INSUFFICIENCY	0.04388092	1.0099264621860091
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.043478300000000004	1.0006600978480389
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.043478300000000004	1.0006600978480389
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.043478300000000004	1.0006600978480389
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.043478300000000004	1.0006600978480389
DESMINOPATHY	0.043478300000000004	1.0006600978480389
SPINAL MUSCULAR ATROPHY, TYPE IV	0.043478300000000004	1.0006600978480389
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.04244375	0.9768497624800807
CHERUBISM	0.04227	0.9728508781630514
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.042239219999999994	0.9721424714909468
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.04219863	0.9712082860841659
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.042174100000000006	0.9706437241716668
OPTIC PATHWAY GLIOMA	0.04146636	0.9543549737455698
BECKER MUSCULAR DYSTROPHY	0.040978749999999994	0.9431325508285815
MYOPATHY, SPHEROID BODY	0.04092263	0.9418409399631331
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.040815000000000004	0.9393638181269209
NEURONAL CEROID LIPOFUSCINOSIS	0.04052256	0.9326332642870817
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0401993	0.9251933831686765
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.03990658	0.9184563850836068
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.039560450000000004	0.9104901472208539
SPINOCEREBELLAR ATAXIA TYPE 4	0.03916258	0.9013331049001835
PRIMARY BILIARY CHOLANGITIS	0.038945480000000005	0.8963365133305314
SPINOCEREBELLAR ATAXIA TYPE 34	0.038792799999999995	0.8928225584670834
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.03866415	0.8898616579353665
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.038628	0.8890296598458091
CAP MYOPATHY	0.038628	0.8890296598458091
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.03853449	0.8868775120904973
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.03843094	0.8844942921133555
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.03839307	0.8836227079459547
GIANT AXONAL NEUROPATHY	0.03835877	0.8828332879052405
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.03835877	0.8828332879052405
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.8762953709674648
MELAS	0.03766612	0.8668918362667347
EPISODIC ATAXIA TYPE 1	0.03763444	0.866162715949247
MUSCULAR DYSTROPHY, BARNES TYPE	0.037466429999999995	0.8622959386594391
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.03743265	0.861518486502724
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.03742284	0.8612927077680474
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	0.03742284	0.8612927077680474
FAMILIAL HYPOALDOSTERONISM	0.037384970000000003	0.8604211236006467
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.03726890000000001	0.8577497538010636
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.037009459999999994	0.8517787002919404
FAMILIAL COLORECTAL CANCER TYPE X	0.036938849999999995	0.8501535997358228
LYNCH SYNDROME	0.036938849999999995	0.8501535997358228
FUNCTIONING GONADOTROPIC ADENOMA	0.03688132	0.8488295374926075
ADENOHYPOPHYSITIS	0.03662634	0.8429611316039389
PANHYPOPHYSITIS	0.03662634	0.8429611316039389
ATTRV30M AMYLOIDOSIS	0.0364583	0.8390936638592851
WOLF-HIRSCHHORN SYNDROME	0.03640748	0.8379240333499818
ATYPICAL RETT SYNDROME	0.03610425	0.83094514591716
POLYMYOSITIS	0.03587573	0.8256857212027569
WILLIAMS SYNDROME	0.03583669	0.8247872092963577
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.035804199999999994	0.8240394466980251
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.035714300000000004	0.8219703836758617
POSTERIOR MENINGOCELE	0.035714300000000004	0.8219703836758617
DISTAL MYOPATHY WITH ANTERIOR TIBIAL ONSET	0.035714300000000004	0.8219703836758617
OPTIC ATROPHY 2	0.035714300000000004	0.8219703836758617
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.035714300000000004	0.8219703836758617
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.035714300000000004	0.8219703836758617
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.035714300000000004	0.8219703836758617
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.035714300000000004	0.8219703836758617
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.035714300000000004	0.8219703836758617
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.035714300000000004	0.8219703836758617
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.035714300000000004	0.8219703836758617
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.035714300000000004	0.8219703836758617
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.03553379	0.8178159168668431
FLYNN-AIRD SYNDROME	0.035422659999999995	0.8152582419652518
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.035422659999999995	0.8152582419652518
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.03526606	0.8116540676685796
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.03526606	0.8116540676685796
MYOTONIC DYSTROPHY 1	0.035207949999999995	0.8103166566316726
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY	0.035207949999999995	0.8103166566316726
SANDHOFF DISEASE	0.035207949999999995	0.8103166566316726
EPISODIC ATAXIA, TYPE 2	0.035207949999999995	0.8103166566316726
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.035207949999999995	0.8103166566316726
GYRATE ATROPHY OF CHOROID AND RETINA	0.0349752	0.8049598777839686
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.0349752	0.8049598777839686
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0349752	0.8049598777839686
SCLEROSTEOSIS 1; SOST1	0.0349174	0.8036296014471382
IATROGENIC BOTULISM	0.034796099999999996	0.800837862352717
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.034788139999999995	0.8006546616668836
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0347253	0.7992083889159075
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.0347253	0.7992083889159075
NEUTRAL LIPID STORAGE MYOPATHY	0.0347253	0.7992083889159075
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03469828	0.7985865192511815
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.03469828	0.7985865192511815
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.03469828	0.7985865192511815
FABRY DISEASE	0.03453043	0.7947234243872198
LENNOX-GASTAUT SYNDROME	0.0344828	0.7936272122432191
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.0344828	0.7936272122432191
PERIORAL MYOCLONIA WITH ABSENCES	0.0344828	0.7936272122432191
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0344828	0.7936272122432191
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0344828	0.7936272122432191
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0344828	0.7936272122432191
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0344828	0.7936272122432191
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0344828	0.7936272122432191
BRAIN-LUNG-THYROID SYNDROME	0.0344828	0.7936272122432191
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	0.7936272122432191
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	0.7936272122432191
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	0.7936272122432191
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0344828	0.7936272122432191
PROGRESSIVE SUPRANUCLEAR PALSY	0.0344828	0.7936272122432191
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0344828	0.7936272122432191
ISOLATED GLYCEROL KINASE DEFICIENCY	0.03439291	0.7915583793726708
NEMALINE MYOPATHY 6	0.034297610000000006	0.7893650344782082
SANDHOFF DISEASE	0.03419985	0.7871150722863646
SHEEHAN SYNDROME	0.03419985	0.7871150722863646
BETHLEM MYOPATHY 2; BTHLM2	0.033799180000000005	0.7778935875133913
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.03377973	0.7774459426214994
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.033561179999999996	0.7724159790676186
PITUICYTOMA	0.03273194	0.7533308865147932
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.03260339	0.75037228749923
13Q12.3 MICRODELETION SYNDROME	0.03258746	0.7500056559759477
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.03241755	0.7460951498792201
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.03241755	0.7460951498792201
TURNPENNY-FRY SYNDROME; TPFS	0.03241755	0.7460951498792201
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.03241755	0.7460951498792201
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.03241755	0.7460951498792201
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.032344609999999996	0.7444164239967214
PROXIMAL MYOTONIC MYOPATHY	0.0322581	0.7424253823721676
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0322581	0.7424253823721676
YOU-HOOVER-FONG SYNDROME; YHFS	0.0322581	0.7424253823721676
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0322581	0.7424253823721676
THROMBOCYTOPENIA 1	0.0322581	0.7424253823721676
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0322581	0.7424253823721676
TAY-SACHS DISEASE	0.0322581	0.7424253823721676
PYRIDOXINE-DEPENDENT EPILEPSY	0.0322581	0.7424253823721676
HYPERKALEMIC PERIODIC PARALYSIS; HYPP	0.0322581	0.7424253823721676
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	0.7424253823721676
SARCOSINEMIA	0.0322581	0.7424253823721676
HYDROXYKYNURENINURIA	0.0322581	0.7424253823721676
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.0322581	0.7424253823721676
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0322581	0.7424253823721676
LESCH-NYHAN SYNDROME	0.0322581	0.7424253823721676
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	0.7424253823721676
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	0.7424253823721676
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	0.7424253823721676
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0322581	0.7424253823721676
OXOGLUTARIC ACIDURIA	0.0322581	0.7424253823721676
DYSTROPHIA MYOTONICA 2	0.0322581	0.7424253823721676
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	0.7424253823721676
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	0.7424253823721676
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	0.7424253823721676
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	0.7424253823721676
NETHERTON SYNDROME; NETH	0.0322581	0.7424253823721676
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	0.7424253823721676
NORMOKALEMIC PERIODIC PARALYSIS	0.0322581	0.7424253823721676
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	0.7424253823721676
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.0322581	0.7424253823721676
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	0.7424253823721676
HUNTINGTON DISEASE	0.0322581	0.7424253823721676
ROWLEY-ROSENBERG SYNDROME	0.0322581	0.7424253823721676
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0322581	0.7424253823721676
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	0.7424253823721676
GRISCELLI SYNDROME TYPE 1	0.0322581	0.7424253823721676
DIENCEPHALIC SYNDROME	0.0322581	0.7424253823721676
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	0.7424253823721676
DESMOID TUMOR	0.0322581	0.7424253823721676
MYOTONIA, POTASSIUM-AGGRAVATED	0.0322581	0.7424253823721676
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	0.7424253823721676
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	0.7424253823721676
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	0.7424253823721676
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0322581	0.7424253823721676
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	0.7424253823721676
ISOLATED CEREBELLAR AGENESIS	0.0322581	0.7424253823721676
LEIGH SYNDROME	0.0322581	0.7424253823721676
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0322581	0.7424253823721676
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	0.7424253823721676
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	0.7424253823721676
WOLFRAM SYNDROME	0.03221447	0.7414212308743146
PEROXISOME BIOGENESIS DISORDER 5B	0.03189198	0.7339990714302926
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.03165782	0.7286098412048218
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.03143333	0.7234431675914121
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.03125	0.7192237980268597
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.03125	0.7192237980268597
PURE AUTONOMIC FAILURE	0.03125	0.7192237980268597
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.03125	0.7192237980268597
ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	0.03125	0.7192237980268597
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.03125	0.7192237980268597
PROLACTINOMA	0.03078648	0.7085558103512946
TSH-SECRETING PITUITARY ADENOMA	0.03078648	0.7085558103512946
NEURALGIC AMYOTROPHY	0.030623050000000002	0.7047944425013257
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.03045445	0.7009140862662111
ALEXANDER DISEASE	0.03041655	0.7000418116439642
ALSTROM SYNDROME; ALMS	0.02954106	0.679892267870059
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.029516970000000003	0.6793378326286361
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0294118	0.6769173280898044
EAR MALFORMATION	0.0294118	0.6769173280898044
AREDYLD	0.0294118	0.6769173280898044
ALKAPTONURIA	0.0294118	0.6769173280898044
OTOONYCHOPERONEAL SYNDROME	0.0294118	0.6769173280898044
FRYNS MICROPHTHALMIA SYNDROME	0.0294118	0.6769173280898044
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.6769173280898044
OSSIFIED EAR CARTILAGES	0.0294118	0.6769173280898044
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.6769173280898044
EAR WITHOUT HELIX	0.0294118	0.6769173280898044
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.6769173280898044
DARWINIAN POINT OF PINNA	0.0294118	0.6769173280898044
OSTEOMA OF MIDDLE EAR	0.0294118	0.6769173280898044
ROSSELLI-GULIENETTI SYNDROME	0.0294118	0.6769173280898044
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	0.6769173280898044
VELOCARDIOFACIAL SYNDROME	0.0294118	0.6769173280898044
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0294118	0.6769173280898044
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0294118	0.6769173280898044
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	0.6769173280898044
BLAU SYNDROME	0.0294118	0.6769173280898044
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	0.6769173280898044
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.6769173280898044
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.6769173280898044
EAR FOLDING	0.0294118	0.6769173280898044
EAR WAX, WET/DRY	0.0294118	0.6769173280898044
HAIRY EARS, Y-LINKED	0.0294118	0.6769173280898044
MUSICAL PERFECT PITCH	0.0294118	0.6769173280898044
FAMILIAL THROMBOCYTOSIS	0.02918584	0.6717168221889358
CRANIOSYNOSTOSIS 2	0.02918584	0.6717168221889358
LINEAR NEVUS SEBACEUS SYNDROME	0.029115999999999996	0.6701094433072013
CONGENITAL HYPOTHYROIDISM	0.029115999999999996	0.6701094433072013
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.02909776	0.6696896467607691
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.02909776	0.6696896467607691
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.028612	0.6585098018926243
HURLER-SCHEIE SYNDROME	0.0285714	0.6575753863342279
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0285714	0.6575753863342279
HALLERMANN-STREIFF SYNDROME; HSS	0.0285714	0.6575753863342279
SCHEIE SYNDROME	0.0285714	0.6575753863342279
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.6575753863342279
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0285714	0.6575753863342279
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0285714	0.6575753863342279
DYSOSTEOSCLEROSIS	0.0285714	0.6575753863342279
MARSHALL-SMITH SYNDROME; MRSHSS	0.0285714	0.6575753863342279
ACHONDROPLASIA	0.0285714	0.6575753863342279
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0285714	0.6575753863342279
XIA-GIBBS SYNDROME	0.0285714	0.6575753863342279
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.0285714	0.6575753863342279
COSTELLO SYNDROME; CSTLO	0.0285714	0.6575753863342279
APNEA, OBSTRUCTIVE SLEEP	0.0285714	0.6575753863342279
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0285635	0.6573935665580866
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.028483480000000002	0.6555518933319071
CENTRONUCLEAR MYOPATHY	0.028483480000000002	0.6555518933319071
NEUROLEPTIC MALIGNANT SYNDROME	0.02839546	0.6535260988134327
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.028165270000000003	0.6482282387792632
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.027795689999999998	0.6397222953784704
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.027795689999999998	0.6397222953784704
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.027765869999999998	0.6390359832614413
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.02768547	0.6371855642738778
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.02768547	0.6371855642738778
CENTRAL NEUROCYTOMA	0.027640309999999998	0.6361461995788732
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.02708428	0.6233490793095332
DYSAUTONOMIA-LIKE DISORDER	0.027006139999999998	0.621550674587043
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.02686957	0.6184074939759542
SNEDDON SYNDROME	0.02675935	0.6158707628713616
BIOTINIDASE DEFICIENCY	0.02675935	0.6158707628713616
KID SYNDROME	0.026685599999999997	0.614173394708018
NARP SYNDROME	0.02665294	0.6134217195322242
NON-FUNCTIONING PITUITARY ADENOMA	0.0266371	0.6130571593734804
CUSHING DISEASE	0.02654461	0.6109284870829363
CEDNIK SYNDROME	0.026177809999999996	0.6024865258312162
BENIGN FAMILIAL INFANTILE EPILEPSY	0.025810069999999997	0.5940229303276514
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02575749	0.5928127931340434
ARACHNOIDITIS	0.025711369999999997	0.5917513338839634
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.025677329999999998	0.5909678977852487
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.025641000000000004	0.5901317569666147
SPINOCEREBELLAR ATAXIA TYPE 13	0.025641000000000004	0.5901317569666147
OSGOOD-SCHLATTER DISEASE	0.025641000000000004	0.5901317569666147
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.025641000000000004	0.5901317569666147
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.025641000000000004	0.5901317569666147
DISTAL ANOCTAMINOPATHY	0.025641000000000004	0.5901317569666147
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.025641000000000004	0.5901317569666147
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.025641000000000004	0.5901317569666147
MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	0.025641000000000004	0.5901317569666147
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.025641000000000004	0.5901317569666147
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.02561382	0.5895062048760429
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.02558467	0.5888353129172433
METACHROMATIC LEUKODYSTROPHY	0.02555797	0.5882208081042092
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.02553724	0.5877437038055501
CEREBROTENDINOUS XANTHOMATOSIS	0.025251689999999997	0.5811717244286998
MEDULLOBLASTOMA	0.02520991	0.5802101509796899
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.0250352	0.5761891721075851
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0250352	0.5761891721075851
KEARNS-SAYRE SYNDROME	0.0250352	0.5761891721075851
PROXIMAL SPINAL MUSCULAR ATROPHY	0.0250352	0.5761891721075851
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02493688	0.5739263214252812
HYPERCALCEMIA, INFANTILE, 1	0.02484936	0.5719120344875752
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.024763129999999998	0.5699274371082518
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.02467945	0.5680015283908474
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.02467945	0.5680015283908474
PITT-HOPKINS SYNDROME	0.02467945	0.5680015283908474
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.024614900000000002	0.5665158997136431
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.024614900000000002	0.5665158997136431
RETINAL CONE DYSTROPHY 4	0.02444116	0.5625172455482291
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.02428158	0.5588444860701771
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.02428158	0.5588444860701771
TRISOMY 20P	0.02428158	0.5588444860701771
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.02391972	0.550516219716449
ADRENOLEUKODYSTROPHY	0.02388946	0.5498197809283438
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.02386937	0.5493574063330683
MUSCLE-EYE-BRAIN DISEASE	0.02386937	0.5493574063330683
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.0238095	0.5479794886118565
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.0238095	0.5479794886118565
BEST VITELLIFORM MACULAR DYSTROPHY	0.0238095	0.5479794886118565
RETINITIS PIGMENTOSA 62; RP62	0.0238095	0.5479794886118565
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0238095	0.5479794886118565
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.0238095	0.5479794886118565
RETINITIS PIGMENTOSA 78; RP78	0.0238095	0.5479794886118565
ISOLATED PLAGIOCEPHALY	0.0238095	0.5479794886118565
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0238095	0.5479794886118565
USHER SYNDROME, TYPE IIIA	0.0238095	0.5479794886118565
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0238095	0.5479794886118565
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.0238095	0.5479794886118565
CAVITARY OPTIC DISC ANOMALIES; CODA	0.0238095	0.5479794886118565
RETINITIS PIGMENTOSA 4; RP4	0.0238095	0.5479794886118565
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.0238095	0.5479794886118565
ADULT-ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY	0.0238095	0.5479794886118565
IDIOPATHIC UVEAL EFFUSION SYNDROME	0.0238095	0.5479794886118565
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0238095	0.5479794886118565
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.02379044	0.547540819632964
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.02378315	0.5473730391053602
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.02378315	0.5473730391053602
INHERITED CREUTZFELDT-JAKOB DISEASE	0.02378315	0.5473730391053602
RIFT VALLEY FEVER	0.02332187	0.5367566053916377
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.02314834	0.5327627844101465
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.023061569999999997	0.530765758843593
PEROXISOME BIOGENESIS DISORDER 3B	0.0228608	0.5261450048618378
SUSAC SYNDROME	0.02272562	0.5230338153252851
XERODERMA PIGMENTOSUM	0.02270594	0.5225808769462399
CHYLOMICRON RETENTION DISEASE	0.02268449	0.5220872017312742
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.02266553	0.5216508342685353
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.02260812	0.5203295338447042
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.02258739	0.519852429546045
PEROXISOME BIOGENESIS DISORDER 14B	0.02245082	0.5167092489349562
MYOPATHY, CONGENITAL	0.02244973	0.516684162408881
CYSTINOSIS	0.02233318	0.51400174533176
COFS SYNDROME	0.0223244	0.5137996722134665
OSTEOPETROSIS AND RELATED DISORDERS	0.022301839999999996	0.5132804501691948
CONGENITAL DISORDER OF GLYCOSYLATION	0.022301839999999996	0.5132804501691948
MULTIPLE CARBOXYLASE DEFICIENCY	0.022263969999999998	0.5124088660017939
PARATHYROID CARCINOMA	0.022156640000000002	0.5099386487140428
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.022156640000000002	0.5099386487140428
PRIMARY PARATHYROID HYPERPLASIA	0.022156640000000002	0.5099386487140428
COCKAYNE SYNDROME A; CSA	0.022023130000000002	0.5068658944972568
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.02173941	0.500336032866019
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.02166127	0.4985376281435288
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.02156081	0.49622552501553585
PREECLAMPSIA	0.021505339999999998	0.4949488740050862
SICKLE CELL ANEMIA	0.02139078	0.49231225709942367
WILLIAMS-BEUREN SYNDROME; WBS	0.02132883	0.49088646784221524
CHERUBISM	0.0212766	0.4896843859551451
INFANTILE REFSUM DISEASE	0.0212766	0.4896843859551451
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 83; RP83	0.0212766	0.4896843859551451
CONE-ROD DYSTROPHY 20; CORD20	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 79	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 11	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 10; RP10	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 1	0.0212766	0.4896843859551451
BARDET-BIEDL SYNDROME 21; BBS21	0.0212766	0.4896843859551451
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 25; RP25	0.0212766	0.4896843859551451
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 14	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 6	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 72; RP72	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 19	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 73; RP73	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 74; RP74	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 13; RP13	0.0212766	0.4896843859551451
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA 69	0.0212766	0.4896843859551451
RETINITIS PIGMENTOSA	0.0212766	0.4896843859551451
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.0212766	0.4896843859551451
GLAUCOMA 1, OPEN ANGLE, M	0.0212766	0.4896843859551451
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.02100134	0.4833492325905091
DISTAL MYOTILINOPATHY	0.02088716	0.4807213614462304
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.02083333	0.4794824553007013
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.0208333	0.47948176484585514
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0208333	0.47948176484585514
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.0208333	0.47948176484585514
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.0208333	0.47948176484585514
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0208333	0.47948176484585514
CRANDALL SYNDROME	0.0208333	0.47948176484585514
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0208333	0.47948176484585514
PARKINSONIAN-PYRAMIDAL SYNDROME	0.0208333	0.47948176484585514
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0208333	0.47948176484585514
POLYARTERITIS NODOSA	0.0208333	0.47948176484585514
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.47948176484585514
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.47948176484585514
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0208333	0.47948176484585514
RAMOS-ARROYO SYNDROME	0.0208333	0.47948176484585514
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.0208333	0.47948176484585514
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0208333	0.47948176484585514
ROMANO-WARD SYNDROME	0.0208333	0.47948176484585514
611426 TENTED EYEBROWS	0.0208333	0.47948176484585514
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.47948176484585514
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0208333	0.47948176484585514
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.0208333	0.47948176484585514
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.47948176484585514
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.47948176484585514
PARKINSON DISEASE, LATE-ONSET; PD	0.0208333	0.47948176484585514
PUPIL, EGG-SHAPED	0.0208333	0.47948176484585514
STICKLER SYNDROME, TYPE III	0.0208333	0.47948176484585514
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.47948176484585514
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.47948176484585514
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.47948176484585514
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.47948176484585514
GAUCHER DISEASE, TYPE I	0.0208333	0.47948176484585514
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.47948176484585514
IMINOGLYCINURIA	0.0208333	0.47948176484585514
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.47948176484585514
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.47948176484585514
YOUNG-ONSET PARKINSON DISEASE	0.0208333	0.47948176484585514
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.0208333	0.47948176484585514
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.47948176484585514
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.47948176484585514
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.47948176484585514
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.47948176484585514
UNIQUE GREEN PHENOMENON	0.0208333	0.47948176484585514
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.47948176484585514
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.47948176484585514
DERMOIDS OF CORNEA	0.0208333	0.47948176484585514
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.47948176484585514
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.47948176484585514
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY (ADLD)	0.0208333	0.47948176484585514
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.47948176484585514
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.47948176484585514
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.47948176484585514
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.47948176484585514
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.47948176484585514
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.020704810000000004	0.47652454673998423
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.020704810000000004	0.47652454673998423
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.020704810000000004	0.47652454673998423
BOUCHER-NEUHAUSER SYNDROME	0.020660989999999997	0.47551602236143886
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.020524419999999998	0.47237284175034994
CHROMOSOME 1P36 DELETION SYNDROME	0.02034401	0.46822067645748516
FARBER DISEASE	0.02027838	0.4667101914058211
GERODERMA OSTEODYSPLASTICA	0.02027838	0.4667101914058211
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.0202333	0.46567266792373946
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02019125	0.4647048803811146
GLIOBLASTOMA	0.02013675	0.4634505540773557
FONTAINE PROGEROID SYNDROME; FPS	0.0201293	0.4632790911239061
SIALIDOSIS TYPE 1	0.02009673	0.46252948731265064
CHARGE SYNDROME	0.019975149999999997	0.45973130397299916
MYOPATHY, SCAPULOHUMEROPERONEAL	0.01994939	0.4591384334118097
REFSUM DISEASE	0.019871439999999997	0.45734440157001144
NATIVE AMERICAN MYOPATHY	0.019783000000000002	0.4553089406836917
WYBURN-MASON SYNDROME	0.019775769999999998	0.45514254106578017
WILSON DISEASE	0.01977438	0.45511054999124395
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.01977438	0.45511054999124395
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.019734869999999998	0.45420122095892257
INSULINOMA	0.019675099999999997	0.45282560475386446
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.019641060000000002	0.4520421686551499
DYSEQUILIBRIUM SYNDROME	0.01957728	0.4505742616523289
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.01950097	0.44881797467545115
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.01950097	0.44881797467545115
X-LINKED CENTRONUCLEAR MYOPATHY	0.019372450000000003	0.4458600661147341
CUTANEOUS MASTOCYTOSIS	0.01920679	0.4420473744545379
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.019121970000000002	0.44009522845298144
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.01907494	0.4390128254059029
LEGIONELLOSIS	0.01880376	0.4327715739003373
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.01871142	0.4306463538840237
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.01871142	0.4306463538840237
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.01871142	0.4306463538840237
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.01871142	0.4306463538840237
KRABBE DISEASE	0.018661040000000004	0.4294868500457969
NEMALINE MYOPATHY 3; NEM3	0.01859029	0.427858527367064
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.01859029	0.427858527367064
NEMALINE MYOPATHY 2; NEM2	0.01859029	0.427858527367064
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.01859029	0.427858527367064
INTERMEDIATE NEMALINE MYOPATHY	0.01859029	0.427858527367064
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.01857485	0.4275031732729349
JUVENILE DERMATOMYOSITIS	0.018544150000000002	0.42679660781375334
ADULT POLYGLUCOSAN BODY DISEASE	0.018446330000000004	0.4245452647122177
MARINESCO-SJÖGREN SYNDROME	0.01834356	0.4221799965610746
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.01834356	0.4221799965610746
GRANULOMATOSIS WITH POLYANGIITIS	0.01822197	0.4193815830698079
LYME DISEASE	0.01800726	0.41443999773622875
COLD AGGLUTININ DISEASE	0.01800726	0.41443999773622875
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01794553	0.41301927181455844
TOXIC EPIDERMAL NECROLYSIS	0.01794553	0.41301927181455844
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.01784798	0.4107741428066377
VON HIPPEL-LINDAU DISEASE	0.01784771	0.4107679287130228
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.017774449999999997	0.40908183797883246
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.017544749999999998	0.4037952553738158
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.01748268	0.402366704297223
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.01748268	0.402366704297223
CRANIOECTODERMAL DYSPLASIA 1	0.01748268	0.402366704297223
MOSAIC MONOSOMY X	0.01748268	0.402366704297223
MONOSOMY X	0.01748268	0.402366704297223
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.01748268	0.402366704297223
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.01748268	0.402366704297223
X SMALL RINGS	0.01748268	0.402366704297223
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.01748268	0.402366704297223
TURNER SYNDROME	0.01748268	0.402366704297223
PMM2-CDG	0.017424699999999998	0.40103228523131584
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.017256530000000003	0.3971618255156623
ADRENOMYODYSTROPHY	0.017256530000000003	0.3971618255156623
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.017256530000000003	0.3971618255156623
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.017256530000000003	0.3971618255156623
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.017256530000000003	0.3971618255156623
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.39681360612160954
TRANSSEXUALITY	0.0172414	0.39681360612160954
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.39681360612160954
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.39681360612160954
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.39681360612160954
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.39681360612160954
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.39681360612160954
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.39681360612160954
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.39681360612160954
DIASTEMATOMYELIA	0.0172414	0.39681360612160954
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.39681360612160954
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.39681360612160954
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.39681360612160954
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.39681360612160954
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.39681360612160954
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.39681360612160954
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.39681360612160954
JUMPING FRENCHMAN OF MAINE	0.0172414	0.39681360612160954
MOSAIC TRISOMY 15	0.0172414	0.39681360612160954
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.39681360612160954
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.39681360612160954
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.39681360612160954
269800 SENILE PLAQUE FORMATION	0.0172414	0.39681360612160954
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.39681360612160954
THUMBS, CONGENITAL CLASPED	0.0172414	0.39681360612160954
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.39681360612160954
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.39681360612160954
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.39681360612160954
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.39681360612160954
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.39681360612160954
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.39681360612160954
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.39681360612160954
CARDIAC ARRHYTHMIA	0.0172414	0.39681360612160954
CERVICAL RIB	0.0172414	0.39681360612160954
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.39681360612160954
RHEUMATOID ARTHRITIS	0.0172414	0.39681360612160954
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.39681360612160954
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.39681360612160954
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.39681360612160954
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.39681360612160954
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.39681360612160954
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.39681360612160954
ALCOHOL DEPENDENCE	0.0172414	0.39681360612160954
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.39681360612160954
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.39681360612160954
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.39681360612160954
PALMOMENTAL REFLEX	0.0172414	0.39681360612160954
MOTION SICKNESS	0.0172414	0.39681360612160954
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.01720927	0.39607412898143024
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01717945	0.39538781686440105
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.01717945	0.39538781686440105
KLEEFSTRA SYNDROME	0.01717945	0.39538781686440105
CORNELIA DE LANGE SYNDROME 3	0.01717945	0.39538781686440105
HSD10 DISEASE	0.01714688	0.39463821305314556
BEHR SYNDROME	0.01714688	0.39463821305314556
CHYLOMICRON RETENTION DISEASE	0.01700306	0.39132817252091445
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.01700306	0.39132817252091445
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.01698138	0.3908292038187954
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.01686316	0.38810835142190775
NEURAMINIDASE DEFICIENCY	0.01664845	0.38316676608832867
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.016533100000000002	0.380511967205052
45,X/46,XY MIXED GONADAL DYSGENESIS	0.01649786	0.37970091291249297
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.01643528	0.37826062410351635
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.01643528	0.37826062410351635
KUSKOKWIM SYNDROME	0.01643528	0.37826062410351635
MULTIPLE SYMMETRIC LIPOMATOSIS	0.01643528	0.37826062410351635
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.01643528	0.37826062410351635
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.01641972	0.3779025081900028
HEREDITARY FOLATE MALABSORPTION	0.01615396	0.371785998859967
ABETALIPOPROTEINEMIA	0.01615156	0.37173076247227854
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.01615156	0.37173076247227854
ZELLWEGER SYNDROME	0.01615156	0.37173076247227854
CARTILAGE-HAIR HYPOPLASIA	0.01615156	0.37173076247227854
ALKAPTONURIA	0.016128999999999998	0.37121154042800697
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.016128999999999998	0.37121154042800697
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.016128999999999998	0.37121154042800697
FETAL PARVOVIRUS SYNDROME	0.016128999999999998	0.37121154042800697
MULTIPLE EPIPHYSEAL DYSPLASIA	0.016128999999999998	0.37121154042800697
STERNAL CLEFT	0.016128999999999998	0.37121154042800697
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.016128999999999998	0.37121154042800697
CARDIOFACIOCUTANEOUS SYNDROME	0.016128999999999998	0.37121154042800697
DIPROSOPUS	0.016128999999999998	0.37121154042800697
MCCUNE-ALBRIGHT SYNDROME	0.016128999999999998	0.37121154042800697
ACRORENAL SYNDROME	0.016128999999999998	0.37121154042800697
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.016128999999999998	0.37121154042800697
FAMILIAL PTERYGIUM OF THE CONJUNCTIVA	0.016128999999999998	0.37121154042800697
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.016128999999999998	0.37121154042800697
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.016128999999999998	0.37121154042800697
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.016128999999999998	0.37121154042800697
WAARDENBURG SYNDROME	0.016128999999999998	0.37121154042800697
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.016128999999999998	0.37121154042800697
NARCOLEPSY TYPE 1	0.016128999999999998	0.37121154042800697
GORLIN-CHAUDHRY-MOSS SYNDROME	0.016128999999999998	0.37121154042800697
TRISOMY 13	0.016128999999999998	0.37121154042800697
RHOMBENCEPHALOSYNAPSIS	0.016128999999999998	0.37121154042800697
FETAL CYTOMEGALOVIRUS SYNDROME	0.016128999999999998	0.37121154042800697
ALG3-CDG	0.016128999999999998	0.37121154042800697
WAARDENBURG-SHAH SYNDROME	0.016128999999999998	0.37121154042800697
CONGENITAL PRIMARY APHAKIA	0.016128999999999998	0.37121154042800697
EEM SYNDROME	0.016128999999999998	0.37121154042800697
AMYLOIDOSIS	0.016128999999999998	0.37121154042800697
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.016128999999999998	0.37121154042800697
MPDU1-CDG	0.016128999999999998	0.37121154042800697
HYPOPLASMINOGENEMIA	0.016128999999999998	0.37121154042800697
6Q25 MICRODELETION SYNDROME	0.016128999999999998	0.37121154042800697
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.016128999999999998	0.37121154042800697
DPM1-CDG	0.016128999999999998	0.37121154042800697
WAARDENBURG SYNDROME TYPE 1	0.016128999999999998	0.37121154042800697
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.016128999999999998	0.37121154042800697
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.016128999999999998	0.37121154042800697
X-LINKED RETINOSCHISIS	0.016128999999999998	0.37121154042800697
RECOMBINANT 8 SYNDROME	0.016128999999999998	0.37121154042800697
1P21.3 MICRODELETION SYNDROME	0.016128999999999998	0.37121154042800697
TOWNES-BROCKS SYNDROME	0.016128999999999998	0.37121154042800697
SILENT SINUS SYNDROME	0.016128999999999998	0.37121154042800697
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.016078679999999998	0.3700534174994722
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.01607342	0.36993235774978844
GLYCOGEN STORAGE DISEASE IV	0.01593685	0.36678917713869946
BRITTLE CORNEA SYNDROME	0.01586212	0.36506925411704994
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.01585366	0.3648745458504481
ACROOSTEOLYSIS DOMINANT TYPE	0.01569856	0.3613048942960812
1P36 DELETION SYNDROME	0.015667320000000002	0.3605859006496698
SYSTEMIC MASTOCYTOSIS	0.01566069	0.3604333101286804
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.01564396	0.36004826647616867
MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1	0.015625	0.3596118990134298
WERNICKE-KORSAKOFF SYNDROME	0.015625	0.3596118990134298
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.015625	0.3596118990134298
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.015625	0.3596118990134298
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.015625	0.3596118990134298
MONONEUROPATHY OF THE MEDIAN NERVE, MILD	0.015625	0.3596118990134298
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.015625	0.3596118990134298
WAARDENBURG-SHAH SYNDROME	0.015625	0.3596118990134298
46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY	0.015625	0.3596118990134298
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.015625	0.3596118990134298
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.015625	0.3596118990134298
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.015625	0.3596118990134298
APOLIPOPROTEIN A-I; APOA1	0.015625	0.3596118990134298
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.015625	0.3596118990134298
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 61	0.015625	0.3596118990134298
AMYLOIDOSIS, FINNISH TYPE	0.015625	0.3596118990134298
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.015625	0.3596118990134298
SPINOCEREBELLAR ATAXIA 23; SCA23	0.015625	0.3596118990134298
MACROPHAGIC MYOFASCIITIS	0.015594300000000002	0.35890533355424825
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.01553055	0.3574381170062734
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.01550387	0.35682407249647
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.01550387	0.35682407249647
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.01550387	0.35682407249647
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.01550387	0.35682407249647
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.015496480000000002	0.3566539904527127
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.015496480000000002	0.3566539904527127
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.015496480000000002	0.3566539904527127
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.015496480000000002	0.3566539904527127
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.015496480000000002	0.3566539904527127
XP21 MICRODELETION SYNDROME	0.015492680000000002	0.35656653283887263
NON-HISTAMINIC ANGIOEDEMA	0.01525766	0.35115750957447983
THYROTOXIC PERIODIC PARALYSIS	0.015134620000000001	0.3483257240989847
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.015134620000000001	0.3483257240989847
PERIPHERAL MOTOR NEUROPATHY-DYSAUTONOMIA SYNDROME	0.015134620000000001	0.3483257240989847
HODGKIN LYMPHOMA	0.015095279999999999	0.3474203076441246
NONAKA MYOPATHY	0.01507618	0.34698071805877057
FAMILIAL COLD URTICARIA	0.01505741	0.3465487234767238
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.01505741	0.3465487234767238
LASSA FEVER	0.01505741	0.3465487234767238
NIPAH VIRUS DISEASE	0.01505741	0.3465487234767238
MARBURG HEMORRHAGIC FEVER	0.01505741	0.3465487234767238
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.01505741	0.3465487234767238
EBOLA HEMORRHAGIC FEVER	0.01505741	0.3465487234767238
LUJO HEMORRHAGIC FEVER	0.01505741	0.3465487234767238
BABESIOSIS	0.01505741	0.3465487234767238
CARNEY TRIAD	0.01505741	0.3465487234767238
HUGHES-STOVIN SYNDROME	0.01505741	0.3465487234767238
SPINAL MUSCULAR ATROPHY, TYPE II	0.014998050000000002	0.34518254348789584
NEUROGENIC THORACIC OUTLET SYNDROME	0.014998050000000002	0.34518254348789584
THORACIC OUTLET SYNDROME	0.014998050000000002	0.34518254348789584
MONOMELIC AMYOTROPHY	0.014998050000000002	0.34518254348789584
ANTISYNTHETASE SYNDROME	0.014998050000000002	0.34518254348789584
L1 SYNDROME	0.01495959	0.34429738037518814
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.01471432	0.3386524517050426
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.01471432	0.3386524517050426
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.01471432	0.3386524517050426
ADULT-ONSET NEMALINE MYOPATHY	0.01471432	0.3386524517050426
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.01471432	0.3386524517050426
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.01459773	0.3359691140214601
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.01457775	0.33550927109395373
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.014467589999999999	0.33297392089905326
GITELMAN SYNDROME	0.01446116	0.33282593341037126
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0144373	0.3322767916561018
LEBER OPTIC ATROPHY AND DYSTONIA	0.0144373	0.3322767916561018
NIEMANN-PICK DISEASE, TYPE A	0.01420171	0.326854649749633
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.01386832	0.3191816250448595
MASTOCYTOSIS	0.013830450000000001	0.3183100408774586
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.013830450000000001	0.3183100408774586
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.013830450000000001	0.3183100408774586
CLASSIC GALACTOSEMIA	0.013732630000000001	0.31605869777592305
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.013698599999999998	0.31527549182882364
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.013698599999999998	0.31527549182882364
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.013698599999999998	0.31527549182882364
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.013698599999999998	0.31527549182882364
RETINAL CAPILLARY MALFORMATION	0.013698599999999998	0.31527549182882364
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.013698599999999998	0.31527549182882364
CONE DYSTROPHY 3	0.013698599999999998	0.31527549182882364
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.013698599999999998	0.31527549182882364
KNOBLOCH SYNDROME	0.013698599999999998	0.31527549182882364
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.013698599999999998	0.31527549182882364
RETINAL CONE DYSTROPHY 1; RCD1	0.013698599999999998	0.31527549182882364
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.013698599999999998	0.31527549182882364
CHOROIDEREMIA	0.013698599999999998	0.31527549182882364
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.013698599999999998	0.31527549182882364
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.013698599999999998	0.31527549182882364
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.013698599999999998	0.31527549182882364
DONNAI-BARROW SYNDROME	0.013698599999999998	0.31527549182882364
ALSTRÖM SYNDROME	0.013698599999999998	0.31527549182882364
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.013698599999999998	0.31527549182882364
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.013698599999999998	0.31527549182882364
BASAL LAMINAR DRUSEN	0.013698599999999998	0.31527549182882364
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.013698599999999998	0.31527549182882364
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.013698599999999998	0.31527549182882364
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.013698599999999998	0.31527549182882364
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.013698599999999998	0.31527549182882364
SENIOR-LOKEN SYNDROME	0.013698599999999998	0.31527549182882364
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.013698599999999998	0.31527549182882364
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.013698599999999998	0.31527549182882364
RETINITIS PIGMENTOSA 80; RP80	0.013698599999999998	0.31527549182882364
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.013698599999999998	0.31527549182882364
CONE-ROD DYSTROPHY 16	0.013698599999999998	0.31527549182882364
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.013698599999999998	0.31527549182882364
JOUBERT SYNDROME 35; JBTS35	0.013698599999999998	0.31527549182882364
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.013698599999999998	0.31527549182882364
CORNEAL DYSTROPHY, LATTICE TYPE I	0.013698599999999998	0.31527549182882364
ANIRIDIA 3	0.013698599999999998	0.31527549182882364
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.0136408	0.31394521549199317
MIXED CONNECTIVE TISSUE DISEASE	0.013565089999999998	0.31220273761203754
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.01349709	0.3106377066275311
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.01346727	0.30995139451050197
GALACTOSEMIA	0.013448910000000001	0.30952883614468524
ATAXIA WITH VITAMIN E DEFICIENCY	0.01343866	0.3092929307389324
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.0133333	0.30686805331940886
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.0133333	0.30686805331940886
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.0133333	0.30686805331940886
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.0133333	0.30686805331940886
MICROPHTHALMIA, SYNDROMIC 1	0.0133333	0.30686805331940886
BARDET-BIEDL SYNDROME 2	0.0133333	0.30686805331940886
ADAMS-OLIVER SYNDROME 1; AOS1	0.0133333	0.30686805331940886
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.0133333	0.30686805331940886
ATRIAL SEPTAL DEFECT 1	0.0133333	0.30686805331940886
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0133333	0.30686805331940886
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.0133333	0.30686805331940886
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0133333	0.30686805331940886
SYNDROMIC DIARRHEA	0.0133333	0.30686805331940886
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.0133333	0.30686805331940886
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.0133333	0.30686805331940886
GRANGE SYNDROME; GRNG	0.0133333	0.30686805331940886
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.0133333	0.30686805331940886
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0133333	0.30686805331940886
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.0133333	0.30686805331940886
FAMILIAL BICUSPID AORTIC VALVE	0.0133333	0.30686805331940886
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0133333	0.30686805331940886
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0133333	0.30686805331940886
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0133333	0.30686805331940886
AORTIC VALVE DISEASE 1; AOVD1	0.0133333	0.30686805331940886
LATERAL MENINGOCELE SYNDROME	0.0133333	0.30686805331940886
KOOLEN-DE VRIES SYNDROME; KDVS	0.0133333	0.30686805331940886
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.0133333	0.30686805331940886
DISTAL MONOSOMY 15Q	0.0133333	0.30686805331940886
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0133333	0.30686805331940886
HUNTER-MACDONALD SYNDROME	0.0133333	0.30686805331940886
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0133333	0.30686805331940886
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0133333	0.30686805331940886
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0133333	0.30686805331940886
PARTIAL ATRIOVENTRICULAR CANAL	0.0133333	0.30686805331940886
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0133333	0.30686805331940886
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	0.0133333	0.30686805331940886
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0133333	0.30686805331940886
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.0133333	0.30686805331940886
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.0133333	0.30686805331940886
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.0133333	0.30686805331940886
KOOLEN-DE VRIES SYNDROME	0.0133333	0.30686805331940886
AORTIC VALVE DISEASE 2; AOVD2	0.0133333	0.30686805331940886
AORTA COARCTATION	0.0133333	0.30686805331940886
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0133333	0.30686805331940886
AORTIC VALVE DISEASE 3; AOVD3	0.0133333	0.30686805331940886
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.01323855	0.30468736676379143
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.013213369999999999	0.3041078449962933
DEND SYNDROME	0.013138750000000001	0.3023904536424129
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.01313523	0.30230944027380313
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.01313523	0.30230944027380313
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.01313523	0.30230944027380313
SPONTANEOUS PERIODIC HYPOTHERMIA	0.01312935	0.30217411112396636
RHEUMATIC FEVER	0.01312935	0.30217411112396636
BEHÇET DISEASE	0.01312935	0.30217411112396636
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.012987	0.2988979028791945
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.012987	0.2988979028791945
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.012987	0.2988979028791945
MULIBREY NANISM	0.012987	0.2988979028791945
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.012987	0.2988979028791945
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.012987	0.2988979028791945
TETRASOMY 12P	0.012987	0.2988979028791945
GRISCELLI SYNDROME	0.012987	0.2988979028791945
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.012987	0.2988979028791945
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.012987	0.2988979028791945
ISOTRETINOIN SYNDROME	0.012987	0.2988979028791945
MADRAS MOTOR NEURON DISEASE	0.012987	0.2988979028791945
MAPLE SYRUP URINE DISEASE	0.012987	0.2988979028791945
POSTERIOR COLUMN ATAXIA	0.012987	0.2988979028791945
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.012987	0.2988979028791945
CAUDAL REGRESSION SEQUENCE	0.012987	0.2988979028791945
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.012987	0.2988979028791945
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.012987	0.2988979028791945
DPM3-CDG	0.012987	0.2988979028791945
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.012987	0.2988979028791945
SYMMETRICAL THALAMIC CALCIFICATIONS	0.012987	0.2988979028791945
RELAPSING FEVER	0.0129385	0.29778166754465674
ALPORT SYNDROME	0.0129385	0.29778166754465674
ACQUIRED METHEMOGLOBINEMIA	0.0129385	0.29778166754465674
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.01293097	0.2976083633782842
STEVENS-JOHNSON SYNDROME	0.01284563	0.2956442494927286
MALT LYMPHOMA	0.01284563	0.2956442494927286
ERDHEIM-CHESTER DISEASE	0.01284563	0.2956442494927286
PELIZAEUS-MERZBACHER DISEASE	0.01278568	0.2942644905585939
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.012700590000000001	0.2923061304634225
INHALATIONAL BOTULISM	0.01263092	0.2907026641591495
PORPHYRIA	0.01263092	0.2907026641591495
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.01257097	0.2893229052250148
LOWRY-MACLEAN SYNDROME	0.012413839999999999	0.285706532892728
SPONDYLO-OCULAR SYNDROME	0.012413839999999999	0.285706532892728
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.01234225	0.28405887747830433
EPISODIC ATAXIA, TYPE 3	0.01234225	0.28405887747830433
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.01228725	0.282793043593777
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.01228052	0.28263815155663397
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.01228052	0.28263815155663397
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.01228052	0.28263815155663397
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012209109999999999	0.2809946388712868
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	0.012209109999999999	0.2809946388712868
PERINEURAL CYST	0.01220216	0.28083468349860563
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.01217424	0.2801921001884965
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.01217072	0.2801110868198867
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.012140429999999999	0.27941395757693527
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.012140429999999999	0.27941395757693527
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.012140429999999999	0.27941395757693527
SEVERE CANAVAN DISEASE	0.012110609999999999	0.2787276454599061
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.012110609999999999	0.2787276454599061
MACHADO-JOSEPH DISEASE TYPE 3	0.012048200000000002	0.2772912692283908
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.012048200000000002	0.2772912692283908
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.012048200000000002	0.2772912692283908
MYHRE SYNDROME	0.012048200000000002	0.2772912692283908
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.012048200000000002	0.2772912692283908
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.012048200000000002	0.2772912692283908
BETHLEM MYOPATHY	0.012048200000000002	0.2772912692283908
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.012048200000000002	0.2772912692283908
HYPOKALEMIC PERIODIC PARALYSIS	0.012048200000000002	0.2772912692283908
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.012048200000000002	0.2772912692283908
GEMIGNANI SYNDROME	0.012048200000000002	0.2772912692283908
CERVICAL HYPERTRICHOSIS-PERIPHERAL NEUROPATHY SYNDROME	0.012048200000000002	0.2772912692283908
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.012048200000000002	0.2772912692283908
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.012048200000000002	0.2772912692283908
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.012048200000000002	0.2772912692283908
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.012048200000000002	0.2772912692283908
APOLIPOPROTEIN A-I DEFICIENCY	0.012048200000000002	0.2772912692283908
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.012048200000000002	0.2772912692283908
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.012048200000000002	0.2772912692283908
PRIMARY ORTHOSTATIC TREMOR	0.012048200000000002	0.2772912692283908
FACIOSCAPULOHUMERAL DYSTROPHY	0.012048200000000002	0.2772912692283908
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.012048200000000002	0.2772912692283908
MCLEOD SYNDROME; MCLDS	0.012034149999999999	0.2769679062087978
MANGANESE POISONING	0.01198918	0.2759329143944853
POSTORGASMIC ILLNESS SYNDROME	0.01187229	0.2732426721624418
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.01187229	0.2732426721624418
AUTOIMMUNE HEMOLYTIC ANEMIA	0.01187229	0.2732426721624418
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.01187229	0.2732426721624418
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.01181056	0.27182194624077144
JOUBERT SYNDROME WITH OCULAR DEFECT	0.01171274	0.2695706031392358
MYOCLONIC EPILEPSY OF LAFORA	0.01171274	0.2695706031392358
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.01171274	0.2695706031392358
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.01171274	0.2695706031392358
SENGERS SYNDROME	0.011704280000000001	0.269375894872634
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.01170428	0.26937589487263397
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.0116279	0.2676179968344487
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.0116279	0.2676179968344487
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.0116279	0.2676179968344487
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.0116279	0.2676179968344487
MYOPATHY, DISTAL 3	0.0116279	0.2676179968344487
TUBULAR AGGREGATE MYOPATHY	0.0116279	0.2676179968344487
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.0116279	0.2676179968344487
SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM	0.0116279	0.2676179968344487
DISTAL NEBULIN MYOPATHY	0.0116279	0.2676179968344487
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0116279	0.2676179968344487
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.0116279	0.2676179968344487
TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.0116279	0.2676179968344487
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0116279	0.2676179968344487
DISTAL MYOPATHY, WELANDER TYPE	0.0116279	0.2676179968344487
GLYCOGEN STORAGE DISEASE WITH SEVERE CARDIOMYOPATHY DUE TO GLYCOGENIN DEFICIENCY	0.0116279	0.2676179968344487
AMISH NEMALINE MYOPATHY	0.0116279	0.2676179968344487
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0116279	0.2676179968344487
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	0.0116279	0.2676179968344487
MICROFORM HOLOPROSENCEPHALY	0.0116279	0.2676179968344487
TIBIAL MUSCULAR DYSTROPHY	0.0116279	0.2676179968344487
NEMALINE MYOPATHY 1; NEM1	0.0116279	0.2676179968344487
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.0116279	0.2676179968344487
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0116279	0.2676179968344487
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.0116279	0.2676179968344487
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0116279	0.2676179968344487
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01160646	0.26712455177109845
AMERICAN TRYPANOSOMIASIS	0.01154918	0.2658062433182671
NEUROFIBROMATOSIS, TYPE II	0.01154918	0.2658062433182671
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.01154918	0.2658062433182671
HEMANGIOBLASTOMA	0.01151131	0.2649346591508662
PAPILLARY TUMOR OF THE PINEAL REGION	0.01151131	0.2649346591508662
DENGUE FEVER	0.01151131	0.2649346591508662
INDOLENT SYSTEMIC MASTOCYTOSIS	0.01151131	0.2649346591508662
SCRUB TYPHUS	0.01151131	0.2649346591508662
YELLOW FEVER	0.01151131	0.2649346591508662
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.01151131	0.2649346591508662
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.01151131	0.2649346591508662
LHERMITTE-DUCLOS DISEASE	0.01151131	0.2649346591508662
PAROXYSMAL COLD HEMOGLOBINURIA	0.01151131	0.2649346591508662
RHABDOID TUMOR	0.01151131	0.2649346591508662
MALARIA	0.01151131	0.2649346591508662
PINEOCYTOMA	0.01151131	0.2649346591508662
CENTRAL DIABETES INSIPIDUS	0.01151131	0.2649346591508662
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.01145931	0.26373787075094957
HENNEKAM-BEEMER SYNDROME	0.01143813	0.26325040962959884
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.01142902	0.26304074150799805
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.01142902	0.26304074150799805
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.01142902	0.26304074150799805
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.01142902	0.26304074150799805
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.01138117	0.2619394660284593
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.01138117	0.2619394660284593
CARCINOID SYNDROME	0.0113433	0.26106788186105845
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.0113433	0.26106788186105845
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01131049	0.2603127544110341
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.01131049	0.2603127544110341
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0112446	0.25879628541737043
MYOPATHY, DISTAL, 4; MPD4	0.011244599999999999	0.25879628541737043
SPINOCEREBELLAR ATAXIA TYPE 7	0.01121431	0.258099156174419
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.01121431	0.258099156174419
PEROXISOME BIOGENESIS DISORDER 11B	0.01121431	0.258099156174419
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.01121431	0.258099156174419
LYSINURIC PROTEIN INTOLERANCE; LPI	0.01111529	0.2558201948790391
NAVAJO NEUROHEPATOPATHY	0.010978449999999999	0.25267080017433524
OSTEOGENESIS IMPERFECTA	0.01076222	0.24769423179522013
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.01064533	0.24500398956317665
ACTH-DEPENDENT CUSHING SYNDROME	0.01064533	0.24500398956317665
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.01064533	0.24500398956317665
GITELMAN SYNDROME	0.01051201	0.24193560822708252
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.01045899	0.24071534436239822
ROUSSY-LÉVY SYNDROME	0.01041067	0.2396032517569372
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.01041067	0.2396032517569372
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.01041067	0.2396032517569372
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.01041067	0.2396032517569372
SMITH-MAGENIS SYNDROME	0.01038085	0.238916939639908
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.01032222	0.23756756071900195
FLYNN-AIRD SYNDROME	0.01032222	0.23756756071900195
NIEMANN-PICK DISEASE TYPE B	0.01032222	0.23756756071900195
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.01032222	0.23756756071900195
ROTHMUND-THOMSON SYNDROME	0.010284350000000001	0.23669597655160113
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0102741	0.23646007114584824
BETA-THALASSEMIA MAJOR	0.01026379	0.23622278483040327
PORPHYRIA VARIEGATA	0.0101889	0.23449917938290787
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.0101889	0.23449917938290787
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.01009713	0.23238707800867023
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.01004881	0.23127498540320923
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.01004881	0.23127498540320923
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01004881	0.23127498540320923
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.01004881	0.23127498540320923
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.01004881	0.23127498540320923
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.01004881	0.23127498540320923
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.01001899	0.23058867328618005
CORNELIA DE LANGE SYNDROME	0.01001899	0.23058867328618005
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00998112	0.2297170891187792
ADENOCARCINOMA OF THE ESOPHAGUS	0.00998112	0.2297170891187792
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00998112	0.2297170891187792
MONOSOMY 22Q13.3	0.00998112	0.2297170891187792
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00994423	0.22886805980968442
WALKER-WARBURG SYNDROME	0.00991224	0.22813180479212025
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00991224	0.22813180479212025
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00991224	0.22813180479212025
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00991224	0.22813180479212025
WALDENSTRÖM MACROGLOBULINEMIA	0.009718939999999999	0.22368297406704535
SARCOIDOSIS	0.009718939999999999	0.22368297406704535
SCHNITZLER SYNDROME	0.009718939999999999	0.22368297406704535
CLASSIC HODGKIN LYMPHOMA	0.009718939999999999	0.22368297406704535
WISKOTT-ALDRICH SYNDROME	0.009718939999999999	0.22368297406704535
COCKAYNE SYNDROME	0.009718939999999999	0.22368297406704535
GAMMA-HEAVY CHAIN DISEASE	0.009718939999999999	0.22368297406704535
MALIGNANT ATROPHIC PAPULOSIS	0.00968107	0.2228113898996445
BOTULISM	0.00968107	0.2228113898996445
AMYOTROPHIC LATERAL SCLEROSIS	0.00968107	0.2228113898996445
CASTLEMAN DISEASE	0.00968107	0.2228113898996445
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00968107	0.2228113898996445
VIRAL HEMORRHAGIC FEVER	0.00968107	0.2228113898996445
LIPOSARCOMA	0.00968107	0.2228113898996445
GASTROINTESTINAL STROMAL TUMOR	0.00968107	0.2228113898996445
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00968107	0.2228113898996445
KAWASAKI DISEASE	0.00968107	0.2228113898996445
PITUITARY APOPLEXY	0.00968107	0.2228113898996445
CINCA SYNDROME	0.00968107	0.2228113898996445
PFAPA SYNDROME	0.00968107	0.2228113898996445
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00968107	0.2228113898996445
MAST SYNDROME	0.00962112	0.22143163096550977
MOEBIUS SYNDROME; MBS	0.00962112	0.22143163096550977
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00962112	0.22143163096550977
OCULODENTODIGITAL DYSPLASIA	0.00956269	0.2200868550769111
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00948455	0.21828845035442085
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00948455	0.21828845035442085
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.0093924	0.21616760321879927
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0093924	0.21616760321879927
TURCOT SYNDROME WITH POLYPOSIS	0.0093924	0.21616760321879927
BENIGN OCCIPITAL EPILEPSY	0.0093924	0.21616760321879927
HYPER-IGD SYNDROME	0.0093924	0.21616760321879927
PAPILLOMA OF CHOROID PLEXUS	0.0093924	0.21616760321879927
POSTENCEPHALITIC PARKINSONISM	0.0093924	0.21616760321879927
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.00935771	0.21536920726508557
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0093374	0.21490176933427196
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0093374	0.21490176933427196
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.00925926	0.21310336461178178
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00925926	0.21310336461178178
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00925926	0.21310336461178178
TRICHOTHIODYSTROPHY	0.00925926	0.21310336461178178
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00922249	0.21225709712207144
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00920083	0.2117585887231831
STIFF SKIN SYNDROME	0.00912269	0.20996018400069286
IMMUNOGLOBULIN A VASCULITIS	0.00908482	0.209088599833292
PORPHYRIA VARIEGATA	0.00908482	0.209088599833292
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00908482	0.209088599833292
ATYPICAL TERATOID RHABDOID TUMOR	0.00908482	0.209088599833292
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0090843	0.20907663194929282
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00905448	0.20839031983226367
POLYCYTHEMIA VERA	0.00892244	0.20535139790293674
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00892244	0.20535139790293674
PRIMARY FAMILIAL POLYCYTHEMIA	0.00892244	0.20535139790293674
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00892244	0.20535139790293674
PONTIAC FEVER	0.00892244	0.20535139790293674
TYPHOID	0.00892244	0.20535139790293674
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.00892244	0.20535139790293674
ADIPOSIS DOLOROSA	0.00892244	0.20535139790293674
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00882462	0.20310005480140117
RIDDLE SYNDROME	0.00882462	0.20310005480140117
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00875443	0.201484620613129
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.00875443	0.201484620613129
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00865661	0.1992332775115934
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00865661	0.1992332775115934
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00865661	0.1992332775115934
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00865661	0.1992332775115934
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00865661	0.1992332775115934
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0085409	0.19657019317016342
NEUROFIBROMATOSIS TYPE 1	0.0085409	0.19657019317016342
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00837289	0.1927034158803556
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00832619	0.19162860783658428
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00832619	0.19162860783658428
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00832619	0.19162860783658428
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00832619	0.19162860783658428
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00832619	0.19162860783658428
CAMURATI-ENGELMANN DISEASE	0.00832619	0.19162860783658428
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00832619	0.19162860783658428
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00829475	0.1909050111578654
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00829475	0.1909050111578654
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00829475	0.1909050111578654
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00829475	0.1909050111578654
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00829475	0.1909050111578654
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00829475	0.1909050111578654
TYPICAL NEMALINE MYOPATHY	0.00829475	0.1909050111578654
RIGID SPINE SYNDROME	0.00829475	0.1909050111578654
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00826446	0.19020788191491395
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00826446	0.19020788191491395
X-LINKED CORNEAL DERMOID	0.00826446	0.19020788191491395
WEILL-MARCHESANI SYNDROME	0.00826446	0.19020788191491395
CATARACT 7; CTRCT7	0.00826446	0.19020788191491395
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.00826446	0.19020788191491395
PFEIFFER SYNDROME TYPE 2	0.00826446	0.19020788191491395
NANCE-HORAN SYNDROME	0.00826446	0.19020788191491395
STICKLER SYNDROME TYPE 1	0.00826446	0.19020788191491395
BLAU SYNDROME	0.00826446	0.19020788191491395
RETINOSCHISIS OF FOVEA	0.00826446	0.19020788191491395
KNOBLOCH SYNDROME 1; KNO1	0.00826446	0.19020788191491395
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00826446	0.19020788191491395
NEOVASCULAR GLAUCOMA	0.00826446	0.19020788191491395
BIRDSHOT CHORIORETINOPATHY	0.00826446	0.19020788191491395
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00826446	0.19020788191491395
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00826446	0.19020788191491395
OPTICOCOCHLEODENTATE DEGENERATION	0.00826446	0.19020788191491395
USHER SYNDROME TYPE 1	0.00826446	0.19020788191491395
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00826446	0.19020788191491395
CONGENITAL GLAUCOMA	0.00826446	0.19020788191491395
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00826446	0.19020788191491395
USHER SYNDROME TYPE 2	0.00826446	0.19020788191491395
RETINAL ARTERIES, TORTUOSITY OF	0.00826446	0.19020788191491395
USHER SYNDROME TYPE 3	0.00826446	0.19020788191491395
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00826446	0.19020788191491395
SRD5A3-CDG	0.00826446	0.19020788191491395
BRITTLE CORNEA SYNDROME	0.00826446	0.19020788191491395
MOHR-TRANEBJAERG SYNDROME	0.00826446	0.19020788191491395
TYROSINEMIA TYPE 2	0.00826446	0.19020788191491395
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.00826446	0.19020788191491395
PEHO SYNDROME	0.00826446	0.19020788191491395
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.00826446	0.19020788191491395
NANCE-HORAN SYNDROME	0.00826446	0.19020788191491395
CATARACT 44; CTRCT44	0.00826446	0.19020788191491395
OPTIC ATROPHY 8	0.00826446	0.19020788191491395
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00826446	0.19020788191491395
SENIOR-LOKEN SYNDROME 3	0.00826446	0.19020788191491395
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00826446	0.19020788191491395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00826446	0.19020788191491395
LATE-ONSET RETINAL DEGENERATION; LORD	0.00826446	0.19020788191491395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00826446	0.19020788191491395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00826446	0.19020788191491395
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.00826446	0.19020788191491395
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00826446	0.19020788191491395
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00826446	0.19020788191491395
UVEAL MELANOMA	0.00826446	0.19020788191491395
ISOLATED ANIRIDIA	0.00826446	0.19020788191491395
ECTODERMAL DYSPLASIA SYNDROME	0.00826446	0.19020788191491395
NEUROMYELITIS OPTICA	0.00826446	0.19020788191491395
LCAT DEFICIENCY	0.00826446	0.19020788191491395
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00826446	0.19020788191491395
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00826446	0.19020788191491395
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00826446	0.19020788191491395
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.00826446	0.19020788191491395
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00826446	0.19020788191491395
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00826446	0.19020788191491395
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00816544	0.1879289206195341
PROPIONIC ACIDEMIA	0.00816544	0.1879289206195341
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.00816544	0.1879289206195341
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00816544	0.1879289206195341
LYSINURIC PROTEIN INTOLERANCE	0.00816544	0.1879289206195341
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00816544	0.1879289206195341
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00816544	0.1879289206195341
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00816544	0.1879289206195341
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00816544	0.1879289206195341
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00815818	0.1877618305467765
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.00815818	0.1877618305467765
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00815818	0.1877618305467765
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00815818	0.1877618305467765
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00815818	0.1877618305467765
CHANARIN-DORFMAN SYNDROME	0.00815818	0.1877618305467765
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00815818	0.1877618305467765
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00815818	0.1877618305467765
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00802535	0.18470472663983548
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00799553	0.18401841452280632
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00799553	0.18401841452280632
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00789203	0.18163634530374134
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.00789203	0.18163634530374134
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00789203	0.18163634530374134
SSR4-CDG	0.00786221	0.1809500331867122
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00786221	0.1809500331867122
MÉNÉTRIER DISEASE	0.00786221	0.1809500331867122
ESOPHAGEAL ATRESIA	0.00786221	0.1809500331867122
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00786221	0.1809500331867122
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00786221	0.1809500331867122
CITRULLINEMIA TYPE I	0.00786221	0.1809500331867122
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00786221	0.1809500331867122
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00786221	0.1809500331867122
ADNP SYNDROME	0.00786221	0.1809500331867122
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00786221	0.1809500331867122
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00772212	0.17772583920701357
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00772212	0.17772583920701357
OCULOCEREBRORENAL SYNDROME OF LOWE	0.00772212	0.17772583920701357
RARE HEREDITARY HEMOCHROMATOSIS	0.00769548	0.17711271530367162
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00769548	0.17711271530367162
PRIMARY SCLEROSING CHOLANGITIS	0.00769548	0.17711271530367162
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.007597660000000001	0.17486137220213605
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.007597660000000001	0.17486137220213605
WOLCOTT-RALLISON SYNDROME	0.007597660000000001	0.17486137220213605
SPONASTRIME DYSPLASIA	0.007597660000000001	0.17486137220213605
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00756216	0.1740443339675775
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00756216	0.1740443339675775
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.00756216	0.1740443339675775
INHALATIONAL ANTHRAX	0.00756216	0.1740443339675775
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.00756216	0.1740443339675775
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.00746434	0.1717929908660419
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.00746434	0.1717929908660419
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.00746434	0.1717929908660419
EPENDYMOMA	0.00746434	0.1717929908660419
SUBEPENDYMOMA	0.00746434	0.1717929908660419
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00746434	0.1717929908660419
REYNOLDS SYNDROME	0.0073922499999999995	0.17013382787084969
ARTERIAL TORTUOSITY SYNDROME	0.0073922499999999995	0.17013382787084969
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00732425	0.16856879688634327
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00732425	0.16856879688634327
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00732425	0.16856879688634327
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00732425	0.16856879688634327
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00732425	0.16856879688634327
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00732425	0.16856879688634327
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00732425	0.16856879688634327
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00731394	0.16833151057089824
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00731394	0.16833151057089824
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00731394	0.16833151057089824
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.00731394	0.16833151057089824
MARFAN SYNDROME	0.00731394	0.16833151057089824
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00731394	0.16833151057089824
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00729443	0.1678824847693141
TENORIO SYNDROME; TNORS	0.00729443	0.1678824847693141
HEREDITARY HYPEREKPLEXIA	0.00729443	0.1678824847693141
16P13.2 MICRODELETION SYNDROME	0.00729443	0.1678824847693141
3Q29 MICRODELETION SYNDROME	0.00729443	0.1678824847693141
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00718062	0.16526312923480413
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.00718062	0.16526312923480413
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0071024799999999996	0.16346472451231392
SECONDARY SHORT BOWEL SYNDROME	0.0071024799999999996	0.16346472451231392
BETA-KETOTHIOLASE DEFICIENCY	0.0071024799999999996	0.16346472451231392
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00709923	0.16338992523731913
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00709923	0.16338992523731913
HEMOCHROMATOSIS TYPE 2	0.00709923	0.16338992523731913
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00709923	0.16338992523731913
SIALIDOSIS TYPE 2	0.00709923	0.16338992523731913
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00709923	0.16338992523731913
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00709923	0.16338992523731913
EPIDERMAL NEVUS SYNDROME	0.00704053	0.16203893525510546
LOWE OCULOCEREBRORENAL SYNDROME	0.00704053	0.16203893525510546
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00704053	0.16203893525510546
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00704053	0.16203893525510546
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00704053	0.16203893525510546
HEART AND BRAIN MALFORMATION SYNDROME	0.00701071	0.16135262313807633
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00701071	0.16135262313807633
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00701071	0.16135262313807633
BAKER-GORDON SYNDROME; BAGOS	0.00701071	0.16135262313807633
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.00699438	0.16097678555017939
GAUCHER DISEASE TYPE 3	0.00699438	0.16097678555017939
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.00699438	0.16097678555017939
CYCLIC VOMITING SYNDROME	0.0069659100000000005	0.16032154390122502
VALINEMIA	0.0069659100000000005	0.16032154390122502
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0069659100000000005	0.16032154390122502
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.0069659100000000005	0.16032154390122502
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.0069659100000000005	0.16032154390122502
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00696239	0.16024053053261528
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00696239	0.16024053053261528
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.00696239	0.16024053053261528
SPINOCEREBELLAR ATAXIA 18	0.00696239	0.16024053053261528
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00696239	0.16024053053261528
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	0.00696239	0.16024053053261528
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.00696239	0.16024053053261528
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.00696239	0.16024053053261528
CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	0.00696239	0.16024053053261528
SPINOCEREBELLAR ATAXIA TYPE 43	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00696239	0.16024053053261528
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.00696239	0.16024053053261528
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00696239	0.16024053053261528
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00696239	0.16024053053261528
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00696239	0.16024053053261528
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB	0.00696239	0.16024053053261528
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00696239	0.16024053053261528
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00696239	0.16024053053261528
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	0.00696239	0.16024053053261528
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00696239	0.16024053053261528
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00696239	0.16024053053261528
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00696239	0.16024053053261528
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00696239	0.16024053053261528
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.00696239	0.16024053053261528
DE SANCTIS-CACCHIONE SYNDROME	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	0.00696239	0.16024053053261528
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00696239	0.16024053053261528
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00693257	0.15955421841558612
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.00693257	0.15955421841558612
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.00693257	0.15955421841558612
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00693257	0.15955421841558612
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00693257	0.15955421841558612
PITT-HOPKINS-LIKE SYNDROME	0.00693257	0.15955421841558612
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00682582	0.15709734992152638
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00682582	0.15709734992152638
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00682582	0.15709734992152638
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.00682582	0.15709734992152638
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.00682582	0.15709734992152638
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00682582	0.15709734992152638
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.00682582	0.15709734992152638
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00682582	0.15709734992152638
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00682582	0.15709734992152638
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00682582	0.15709734992152638
HOLOPROSENCEPHALY	0.006796	0.15641103780449722
MUCOLIPIDOSIS TYPE III	0.00671066	0.15444692391894166
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.00671066	0.15444692391894166
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00671066	0.15444692391894166
ATYPICAL JUVENILE PARKINSONISM	0.006632519999999999	0.15264851919645142
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00661284	0.15219558081740603
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00661284	0.15219558081740603
NEUROFIBROMATOSIS TYPE 2	0.00661284	0.15219558081740603
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00661284	0.15219558081740603
2P15P16.1 MICRODELETION SYNDROME	0.00661284	0.15219558081740603
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00661284	0.15219558081740603
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00661284	0.15219558081740603
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00661284	0.15219558081740603
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00661284	0.15219558081740603
CADASIL	0.00661284	0.15219558081740603
INCONTINENTIA PIGMENTI	0.00661284	0.15219558081740603
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00661284	0.15219558081740603
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00661284	0.15219558081740603
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.0065347	0.15039717609491582
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0065347	0.15039717609491582
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0065347	0.15039717609491582
METACHROMATIC LEUKODYSTROPHY	0.0065347	0.15039717609491582
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.00649595	0.14950533858536255
X-LINKED SIDEROBLASTIC ANEMIA	0.00649595	0.14950533858536255
EISENMENGER SYNDROME	0.00649595	0.14950533858536255
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00649595	0.14950533858536255
ACTH-INDEPENDENT CUSHING SYNDROME	0.00649595	0.14950533858536255
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00649595	0.14950533858536255
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.00649595	0.14950533858536255
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.00649595	0.14950533858536255
TAKAYASU ARTERITIS	0.00649595	0.14950533858536255
MYXEDEMA	0.00649595	0.14950533858536255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00649595	0.14950533858536255
LIDDLE SYNDROME	0.00649595	0.14950533858536255
EVANS SYNDROME	0.00649595	0.14950533858536255
ACUTE PROMYELOCYTIC LEUKEMIA	0.00649595	0.14950533858536255
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00649595	0.14950533858536255
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.00649595	0.14950533858536255
ATHYREOSIS	0.00649595	0.14950533858536255
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.00639813	0.14725399548382695
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00639813	0.14725399548382695
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00639813	0.14725399548382695
COFFIN-LOWRY SYNDROME	0.00639813	0.14725399548382695
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00639813	0.14725399548382695
PEROXISOME BIOGENESIS DISORDER 6B	0.00625098	0.14386731446367806
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00625098	0.14386731446367806
TANGIER DISEASE; TGD	0.00625098	0.14386731446367806
MICRO SYNDROME	0.00617284	0.14206890974118785
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.00617284	0.14206890974118785
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.00617284	0.14206890974118785
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00617284	0.14206890974118785
RABSON-MENDENHALL SYNDROME	0.00617284	0.14206890974118785
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.00617284	0.14206890974118785
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00617284	0.14206890974118785
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.00617284	0.14206890974118785
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.00617284	0.14206890974118785
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.00617284	0.14206890974118785
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00617284	0.14206890974118785
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.00617284	0.14206890974118785
MACHADO-JOSEPH DISEASE TYPE 2	0.00617284	0.14206890974118785
PRIMARY ERYTHROMELALGIA	0.00617284	0.14206890974118785
MEDNIK SYNDROME	0.00617284	0.14206890974118785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.00617284	0.14206890974118785
FOLATE MALABSORPTION, HEREDITARY	0.00617284	0.14206890974118785
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.00617284	0.14206890974118785
FELTY SYNDROME	0.00617284	0.14206890974118785
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00617284	0.14206890974118785
CRANIAL NERVES, RECURRENT PARESIS OF	0.00617284	0.14206890974118785
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00617284	0.14206890974118785
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00617284	0.14206890974118785
SPINOCEREBELLAR ATAXIA TYPE 11	0.00617284	0.14206890974118785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00617284	0.14206890974118785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.00617284	0.14206890974118785
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00617284	0.14206890974118785
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.00617284	0.14206890974118785
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00617284	0.14206890974118785
NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE	0.00617284	0.14206890974118785
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00617284	0.14206890974118785
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.00617284	0.14206890974118785
CARPAL TUNNEL SYNDROME	0.00617284	0.14206890974118785
SÉZARY SYNDROME	0.00617284	0.14206890974118785
PRIMARY HYPEROXALURIA	0.00617284	0.14206890974118785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00617284	0.14206890974118785
DISORDER OF BILE ACID SYNTHESIS	0.00617284	0.14206890974118785
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00617284	0.14206890974118785
NEUROPATHY, PAINFUL	0.00617284	0.14206890974118785
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00617284	0.14206890974118785
THALIDOMIDE SUSCEPTIBILITY	0.00617284	0.14206890974118785
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00617284	0.14206890974118785
IRIDA SYNDROME	0.00617284	0.14206890974118785
MACHADO-JOSEPH DISEASE TYPE 1	0.00617284	0.14206890974118785
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00617284	0.14206890974118785
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00617284	0.14206890974118785
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.00617284	0.14206890974118785
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00617284	0.14206890974118785
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00617284	0.14206890974118785
ACRODYSOSTOSIS	0.00617284	0.14206890974118785
FAMILIAL MULTIPLE LIPOMATOSIS	0.00617284	0.14206890974118785
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.00617284	0.14206890974118785
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.00613497	0.14119732557378697
ACUTE INTERMITTENT PORPHYRIA	0.00613497	0.14119732557378697
HEREDITARY COPROPORPHYRIA	0.00613497	0.14119732557378697
HYDATIDIFORM MOLE	0.00613497	0.14119732557378697
CLASSIC PHENYLKETONURIA	0.00613497	0.14119732557378697
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00613497	0.14119732557378697
PSEUDOMYXOMA PERITONEI	0.00613497	0.14119732557378697
GALACTOSE EPIMERASE DEFICIENCY	0.00613497	0.14119732557378697
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00613497	0.14119732557378697
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.00613497	0.14119732557378697
FAMILIAL PAROXYSMAL ATAXIA	0.00613497	0.14119732557378697
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00613497	0.14119732557378697
FAMILIAL MEDITERRANEAN FEVER	0.00613497	0.14119732557378697
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.00613497	0.14119732557378697
GRFOMA	0.00613497	0.14119732557378697
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00613497	0.14119732557378697
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00613497	0.14119732557378697
SOMATOSTATINOMA	0.00613497	0.14119732557378697
VIPOMA	0.00613497	0.14119732557378697
CREST SYNDROME	0.00613497	0.14119732557378697
GLUCAGONOMA	0.00613497	0.14119732557378697
PPOMA	0.00613497	0.14119732557378697
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.00613497	0.14119732557378697
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00613497	0.14119732557378697
GRISCELLI SYNDROME TYPE 2	0.00613497	0.14119732557378697
NEPHROGENIC DIABETES INSIPIDUS	0.00613497	0.14119732557378697
RECURRENT ACUTE PANCREATITIS	0.00613497	0.14119732557378697
PRIMARY PERITONEAL CARCINOMA	0.00613497	0.14119732557378697
EPISODIC ATAXIA TYPE 6	0.00613497	0.14119732557378697
RABIES	0.00613497	0.14119732557378697
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00613497	0.14119732557378697
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00613497	0.14119732557378697
BURKITT LYMPHOMA	0.00613497	0.14119732557378697
PEDIATRIC-ONSET GRAVES DISEASE	0.00613497	0.14119732557378697
INTESTINAL BOTULISM	0.00613497	0.14119732557378697
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00613497	0.14119732557378697
HALL-RIGGS SYNDROME	0.00613497	0.14119732557378697
PAROXYSMAL HEMICRANIA	0.00613497	0.14119732557378697
FAMILIAL PANCREATIC CARCINOMA	0.00613497	0.14119732557378697
DRACUNCULIASIS	0.00613497	0.14119732557378697
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.00613497	0.14119732557378697
CHOLESTERYL ESTER STORAGE DISEASE	0.00613497	0.14119732557378697
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.00613497	0.14119732557378697
WOLMAN DISEASE	0.00613497	0.14119732557378697
HIRSCHSPRUNG DISEASE	0.00613497	0.14119732557378697
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00613497	0.14119732557378697
FOODBORNE BOTULISM	0.00613497	0.14119732557378697
MICROSCOPIC POLYANGIITIS	0.00613497	0.14119732557378697
NEUROENDOCRINE TUMOR OF STOMACH	0.00613497	0.14119732557378697
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00611441	0.14072413385258914
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00611441	0.14072413385258914
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00611441	0.14072413385258914
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00603627	0.13892572913009896
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.00603627	0.13892572913009896
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.00603627	0.13892572913009896
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00603627	0.13892572913009896
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00603627	0.13892572913009896
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00603627	0.13892572913009896
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00603627	0.13892572913009896
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00603627	0.13892572913009896
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00603627	0.13892572913009896
SNEDDON SYNDROME	0.00537634	0.12373733357707926
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.00537634	0.12373733357707926
CROUZON DISEASE	0.00537634	0.12373733357707926
PARKES WEBER SYNDROME	0.00537634	0.12373733357707926
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00537634	0.12373733357707926
PARIETAL FORAMINA	0.00537634	0.12373733357707926
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00537634	0.12373733357707926
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.12373733357707926
THYMIC TUMOR	0.00537634	0.12373733357707926
INTERNAL CAROTID AGENESIS	0.00537634	0.12373733357707926
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00537634	0.12373733357707926
BRUNNER SYNDROME; BRNRS	0.00537634	0.12373733357707926
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.12373733357707926
PITUITARY CARCINOMA	0.00537634	0.12373733357707926
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00537634	0.12373733357707926
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.00537634	0.12373733357707926
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.00537634	0.12373733357707926
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.12373733357707926
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.00537634	0.12373733357707926
SYDENHAM CHOREA	0.00537634	0.12373733357707926
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.12373733357707926
GANGLIOCYTOMA	0.00537634	0.12373733357707926
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.12373733357707926
MARSILI SYNDROME; MARSIS	0.00537634	0.12373733357707926
CUTANEOUS MASTOCYTOMA	0.00537634	0.12373733357707926
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.12373733357707926
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00537634	0.12373733357707926
AICARDI-GOUTIÈRES SYNDROME	0.00537634	0.12373733357707926
MAJEED SYNDROME	0.00537634	0.12373733357707926
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00537634	0.12373733357707926
ROSAÏ-DORFMAN DISEASE	0.00537634	0.12373733357707926
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00537634	0.12373733357707926
15Q OVERGROWTH SYNDROME	0.00537634	0.12373733357707926
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.00537634	0.12373733357707926
SOLAR URTICARIA	0.00537634	0.12373733357707926
IDIOPATHIC PANUVEITIS	0.00537634	0.12373733357707926
PRIMARY CILIARY DYSKINESIA	0.00537634	0.12373733357707926
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00537634	0.12373733357707926
PINEOBLASTOMA	0.00537634	0.12373733357707926
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.12373733357707926
LAFORA DISEASE	0.00537634	0.12373733357707926
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.00537634	0.12373733357707926
HYDROXYKYNURENINURIA	0.00537634	0.12373733357707926
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.12373733357707926
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.12373733357707926
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.12373733357707926
TEMPI SYNDROME	0.00537634	0.12373733357707926
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00537634	0.12373733357707926
PRIMARY LIPODYSTROPHY	0.00520833	0.11987055628727147
300270 ADRENOMYODYSTROPHY	0.00520833	0.11987055628727147
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00520833	0.11987055628727147
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00520833	0.11987055628727147
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.00520833	0.11987055628727147
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00520833	0.11987055628727147
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00520833	0.11987055628727147
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00520833	0.11987055628727147
STROMME SYNDROME; STROMS	0.00520833	0.11987055628727147
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00520833	0.11987055628727147
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00520833	0.11987055628727147
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00520833	0.11987055628727147
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.00520833	0.11987055628727147
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00520833	0.11987055628727147
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.00520833	0.11987055628727147
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00520833	0.11987055628727147
CENTRAL CORE DISEASE	0.00520833	0.11987055628727147
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00520833	0.11987055628727147
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00520833	0.11987055628727147
DISTAL MYOPATHY	0.00520833	0.11987055628727147
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00520833	0.11987055628727147
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00520833	0.11987055628727147
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00520833	0.11987055628727147
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00520833	0.11987055628727147
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00520833	0.11987055628727147
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00520833	0.11987055628727147
HYPOPHOSPHATASIA, CHILDHOOD	0.00520833	0.11987055628727147
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.00520833	0.11987055628727147
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00520833	0.11987055628727147
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00520833	0.11987055628727147
VICI SYNDROME; VICIS	0.00520833	0.11987055628727147
XANTHINURIA, TYPE I	0.00520833	0.11987055628727147
ACQUIRED PARTIAL LIPODYSTROPHY	0.00520833	0.11987055628727147
ADDUCTED THUMBS SYNDROME	0.00520833	0.11987055628727147
MARINESCO-SJOGREN SYNDROME; MSS	0.00520833	0.11987055628727147
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00520833	0.11987055628727147
CAREY-FINEMAN-ZITER SYNDROME	0.00520833	0.11987055628727147
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00520833	0.11987055628727147
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00520833	0.11987055628727147
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00520833	0.11987055628727147
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00520833	0.11987055628727147
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00520833	0.11987055628727147
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00520833	0.11987055628727147
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.00520833	0.11987055628727147
AXIAL OSTEOMALACIA	0.00520833	0.11987055628727147
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.00520833	0.11987055628727147
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00520833	0.11987055628727147
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00520833	0.11987055628727147
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00520833	0.11987055628727147
SANJAD-SAKATI SYNDROME	0.00520833	0.11987055628727147
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00520833	0.11987055628727147
MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS	0.00520833	0.11987055628727147
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00520833	0.11987055628727147
BETHLEM MYOPATHY 1	0.00520833	0.11987055628727147
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00520833	0.11987055628727147
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00520833	0.11987055628727147
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.00520833	0.11987055628727147
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00520833	0.11987055628727147
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00520833	0.11987055628727147
HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	0.00520833	0.11987055628727147
B4GALT1-CDG	0.00520833	0.11987055628727147
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00520833	0.11987055628727147
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00520833	0.11987055628727147
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.00520833	0.11987055628727147
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00520833	0.11987055628727147
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	0.00520833	0.11987055628727147
CARNITINE DEFICIENCY, MYOPATHIC	0.00520833	0.11987055628727147
ACQUIRED GENERALIZED LIPODYSTROPHY	0.00520833	0.11987055628727147
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00520833	0.11987055628727147
FINGERPRINT BODY MYOPATHY	0.00520833	0.11987055628727147
CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH	0.00520833	0.11987055628727147
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00520833	0.11987055628727147
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00520833	0.11987055628727147
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00520833	0.11987055628727147
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00520833	0.11987055628727147
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00520833	0.11987055628727147
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00520833	0.11987055628727147
SALIH MYOPATHY; SALMY	0.00520833	0.11987055628727147
IMMUNODEFICIENCY 9; IMD9	0.00520833	0.11987055628727147
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.00520833	0.11987055628727147
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00520833	0.11987055628727147
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.00520833	0.11987055628727147
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00520833	0.11987055628727147
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00520833	0.11987055628727147
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.00520833	0.11987055628727147
VACUOLAR MYOPATHY WITH SARCOPLASMIC RETICULUM PROTEIN AGGREGATES	0.00520833	0.11987055628727147
STORMORKEN SYNDROME; STRMK	0.00520833	0.11987055628727147
CRANIOECTODERMAL DYSPLASIA	0.00414938	0.09549865097781411
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00414938	0.09549865097781411
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00414938	0.09549865097781411
AMISH LETHAL MICROCEPHALY	0.00414938	0.09549865097781411
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00414938	0.09549865097781411
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00414938	0.09549865097781411
MU-HEAVY CHAIN DISEASE	0.00414938	0.09549865097781411
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00414938	0.09549865097781411
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00414938	0.09549865097781411
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00414938	0.09549865097781411
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00414938	0.09549865097781411
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00414938	0.09549865097781411
EHLERS-DANLOS SYNDROME, TYPE VI	0.00414938	0.09549865097781411
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00414938	0.09549865097781411
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00414938	0.09549865097781411
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.00414938	0.09549865097781411
LICHTENSTEIN SYNDROME	0.00414938	0.09549865097781411
GERODERMA OSTEODYSPLASTICUM; GO	0.00414938	0.09549865097781411
ODONTOCHONDRODYSPLASIA; ODCD	0.00414938	0.09549865097781411
GLYCOGEN STORAGE DISEASE IA	0.00414938	0.09549865097781411
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00414938	0.09549865097781411
GLYCOGEN STORAGE DISEASE IB	0.00414938	0.09549865097781411
OVARIAN DYSGENESIS 1	0.00414938	0.09549865097781411
DYSKERATOSIS CONGENITA	0.00414938	0.09549865097781411
AFRICAN IRON OVERLOAD	0.00414938	0.09549865097781411
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00414938	0.09549865097781411
HEMOCHROMATOSIS, TYPE 1	0.00414938	0.09549865097781411
EXTENSOR TENDONS OF FINGER ANOMALIES	0.00414938	0.09549865097781411
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00414938	0.09549865097781411
CLEIDOCRANIAL DYSPLASIA	0.00414938	0.09549865097781411
OVARIAN DYSGENESIS 8; ODG8	0.00414938	0.09549865097781411
OSTEOPOROSIS	0.00414938	0.09549865097781411
CLASSIC HOMOCYSTINURIA	0.00414938	0.09549865097781411
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00414938	0.09549865097781411
601220 OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH	0.00414938	0.09549865097781411
LATHOSTEROLOSIS	0.00414938	0.09549865097781411
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00414938	0.09549865097781411
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00414938	0.09549865097781411
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00414938	0.09549865097781411
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00414938	0.09549865097781411
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00414938	0.09549865097781411
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00414938	0.09549865097781411
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00414938	0.09549865097781411
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00414938	0.09549865097781411
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00414938	0.09549865097781411
MYCETOMA	0.00414938	0.09549865097781411
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00414938	0.09549865097781411
WARBURG MICRO SYNDROME 1	0.00414938	0.09549865097781411
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00414938	0.09549865097781411
FRANK-TER HAAR SYNDROME; FTHS	0.00414938	0.09549865097781411
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00414938	0.09549865097781411
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00414938	0.09549865097781411
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00414938	0.09549865097781411
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00414938	0.09549865097781411
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00414938	0.09549865097781411
MENKES DISEASE	0.00414938	0.09549865097781411
ESTROGEN RESISTANCE SYNDROME	0.00414938	0.09549865097781411
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	0.00414938	0.09549865097781411
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	0.00414938	0.09549865097781411
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00414938	0.09549865097781411
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00414938	0.09549865097781411
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00414938	0.09549865097781411
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00414938	0.09549865097781411
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00414938	0.09549865097781411
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00414938	0.09549865097781411
MACS SYNDROME	0.00414938	0.09549865097781411
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00414938	0.09549865097781411
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.00414938	0.09549865097781411
BETA-THALASSEMIA INTERMEDIA	0.00414938	0.09549865097781411
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.00414938	0.09549865097781411
FORSYTHE-WAKELING SYNDROME; FWS	0.00414938	0.09549865097781411
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00414938	0.09549865097781411
ATYPICAL WERNER SYNDROME	0.00414938	0.09549865097781411
LOEYS-DIETZ SYNDROME 3; LDS3	0.00414938	0.09549865097781411
46,XY PARTIAL GONADAL DYSGENESIS	0.00414938	0.09549865097781411
IDIOPATHIC HYPERCALCIURIA	0.00414938	0.09549865097781411
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	0.00414938	0.09549865097781411
WERNER SYNDROME; WRN	0.00414938	0.09549865097781411
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00414938	0.09549865097781411
AROMATASE DEFICIENCY	0.00414938	0.09549865097781411
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00414938	0.09549865097781411
FAMILIAL HYPERPROLACTINEMIA	0.00414938	0.09549865097781411
URBAN-ROGERS-MEYER SYNDROME	0.00414938	0.09549865097781411
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00414938	0.09549865097781411
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00414938	0.09549865097781411
BRUCK SYNDROME	0.00414938	0.09549865097781411
OSTEOPOROSIS, JUVENILE	0.00414938	0.09549865097781411
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00414938	0.09549865097781411
PRIMROSE SYNDROME; PRIMS	0.00414938	0.09549865097781411
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00414938	0.09549865097781411
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00414938	0.09549865097781411
THROMBOCYTOPENIA 6	0.00414938	0.09549865097781411
PACHYDERMOPERIOSTOSIS	0.00414938	0.09549865097781411
JUVENILE PAGET DISEASE	0.00414938	0.09549865097781411
SHASHI-PENA SYNDROME; SHAPNS	0.00414938	0.09549865097781411
MORQUIO SYNDROME A	0.00414938	0.09549865097781411
DESBUQUOIS DYSPLASIA 1	0.00414938	0.09549865097781411
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00414938	0.09549865097781411
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.00414938	0.09549865097781411
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00414938	0.09549865097781411
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00414938	0.09549865097781411
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00414938	0.09549865097781411
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00414938	0.09549865097781411
INFANTILE SYSTEMIC HYALINOSIS	0.00414938	0.09549865097781411
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00414938	0.09549865097781411
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00414938	0.09549865097781411
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00414938	0.09549865097781411
NEU-LAXOVA SYNDROME	0.00414938	0.09549865097781411
PREMATURE OVARIAN FAILURE 2B	0.00414938	0.09549865097781411
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00414938	0.09549865097781411
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00414938	0.09549865097781411
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	0.00414938	0.09549865097781411
WERNER SYNDROME	0.00414938	0.09549865097781411
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.00414938	0.09549865097781411
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00401606	0.09243026964172
ENTERIC ANENDOCRINOSIS	0.00401606	0.09243026964172
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.00401606	0.09243026964172
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.09243026964172
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00401606	0.09243026964172
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00401606	0.09243026964172
HEREDITARY FRUCTOSE INTOLERANCE	0.00401606	0.09243026964172
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00401606	0.09243026964172
PANCREATOBLASTOMA	0.00401606	0.09243026964172
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00401606	0.09243026964172
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.00401606	0.09243026964172
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00401606	0.09243026964172
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.00401606	0.09243026964172
GRAFT VERSUS HOST DISEASE	0.00401606	0.09243026964172
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00401606	0.09243026964172
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00401606	0.09243026964172
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.00401606	0.09243026964172
19P13.13 MICRODELETION SYNDROME	0.00401606	0.09243026964172
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00401606	0.09243026964172
HISTIOCYTOID CARDIOMYOPATHY	0.00401606	0.09243026964172
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00401606	0.09243026964172
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.00401606	0.09243026964172
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.00401606	0.09243026964172
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.00401606	0.09243026964172
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00401606	0.09243026964172
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00401606	0.09243026964172
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00401606	0.09243026964172
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00401606	0.09243026964172
KRABBE DISEASE	0.00401606	0.09243026964172
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00401606	0.09243026964172
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00401606	0.09243026964172
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.09243026964172
HYPOPHOSPHATASIA, INFANTILE	0.00401606	0.09243026964172
HYPOADRENOCORTICISM, FAMILIAL	0.00401606	0.09243026964172
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00401606	0.09243026964172
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00401606	0.09243026964172
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00401606	0.09243026964172
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00401606	0.09243026964172
HYPERLIPOPROTEINEMIA, TYPE I	0.00401606	0.09243026964172
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.00401606	0.09243026964172
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00401606	0.09243026964172
MOWAT-WILSON SYNDROME; MOWS	0.00401606	0.09243026964172
HEREDITARY ANGIOEDEMA TYPE 1	0.00401606	0.09243026964172
GALACTOSEMIA	0.00401606	0.09243026964172
GALACTOSE EPIMERASE DEFICIENCY	0.00401606	0.09243026964172
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.00401606	0.09243026964172
ISOLATED COMPLEX I DEFICIENCY	0.00401606	0.09243026964172
MAPLE SYRUP URINE DISEASE; MSUD	0.00401606	0.09243026964172
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.00401606	0.09243026964172
CITRULLINEMIA TYPE II	0.00401606	0.09243026964172
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00401606	0.09243026964172
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00401606	0.09243026964172
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00401606	0.09243026964172
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00401606	0.09243026964172
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.09243026964172
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00401606	0.09243026964172
COLCHICINE POISONING	0.00401606	0.09243026964172
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00401606	0.09243026964172
CONGENITAL SHORT BOWEL SYNDROME	0.00401606	0.09243026964172
ATRESIA OF SMALL INTESTINE	0.00401606	0.09243026964172
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00401606	0.09243026964172
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00401606	0.09243026964172
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00401606	0.09243026964172
EOSINOPHILIC GASTROENTERITIS	0.00401606	0.09243026964172
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00401606	0.09243026964172
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00401606	0.09243026964172
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00401606	0.09243026964172
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00401606	0.09243026964172
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00401606	0.09243026964172
CAROLI DISEASE, ISOLATED	0.00401606	0.09243026964172
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.00401606	0.09243026964172
METHYLMALONIC ACIDURIA, CBLA TYPE	0.00401606	0.09243026964172
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00401606	0.09243026964172
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.00401606	0.09243026964172
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.00401606	0.09243026964172
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.09243026964172
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00401606	0.09243026964172
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00401606	0.09243026964172
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00401606	0.09243026964172
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00401606	0.09243026964172
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00401606	0.09243026964172
PORPHYRIA, ACUTE HEPATIC	0.00401606	0.09243026964172
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.00401606	0.09243026964172
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00401606	0.09243026964172
EPISODIC ATAXIA, TYPE 6	0.00401606	0.09243026964172
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00401606	0.09243026964172
LARYNGOTRACHEAL ANGIOMA	0.00401606	0.09243026964172
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.00401606	0.09243026964172
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00401606	0.09243026964172
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00401606	0.09243026964172
ANGIOEDEMA, HEREDITARY, TYPE III	0.00401606	0.09243026964172
CONGENITAL PANCREATIC CYST	0.00401606	0.09243026964172
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00401606	0.09243026964172
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00401606	0.09243026964172
MEVALONIC ACIDURIA; MEVA	0.00401606	0.09243026964172
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00401606	0.09243026964172
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00401606	0.09243026964172
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00401606	0.09243026964172
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00401606	0.09243026964172
VISCERAL MYOPATHY; VSCM	0.00401606	0.09243026964172
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00401606	0.09243026964172
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00401606	0.09243026964172
ACID PHOSPHATASE DEFICIENCY	0.00401606	0.09243026964172
CITRULLINEMIA, CLASSIC	0.00401606	0.09243026964172
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00401606	0.09243026964172
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.00401606	0.09243026964172
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.00401606	0.09243026964172
ARGININOSUCCINIC ACIDURIA	0.00401606	0.09243026964172
INFANTILE LIVER FAILURE SYNDROME 2	0.00401606	0.09243026964172
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00401606	0.09243026964172
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00401606	0.09243026964172
ALPHA-METHYLACETOACETIC ACIDURIA	0.00401606	0.09243026964172
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.00401606	0.09243026964172
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00401606	0.09243026964172
PEUTZ-JEGHERS SYNDROME	0.00401606	0.09243026964172
LESCH-NYHAN SYNDROME; LNS	0.00401606	0.09243026964172
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.00401606	0.09243026964172
LIVER FAILURE, INFANTILE, TRANSIENT	0.00401606	0.09243026964172
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00401606	0.09243026964172
CRYPTOSPORIDIOSIS	0.00401606	0.09243026964172
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00387597	0.08920607566202135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.00387597	0.08920607566202135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00387597	0.08920607566202135
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.00387597	0.08920607566202135
INFANT BOTULISM	0.00387597	0.08920607566202135
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00387597	0.08920607566202135
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00387597	0.08920607566202135
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.00387597	0.08920607566202135
CHÉDIAK-HIGASHI SYNDROME	0.00387597	0.08920607566202135
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.00387597	0.08920607566202135
DEAFNESS, X-LINKED 5; DFNX5	0.00387597	0.08920607566202135
USHER SYNDROME, TYPE IE; USH1E	0.00387597	0.08920607566202135
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.00387597	0.08920607566202135
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00387597	0.08920607566202135
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00387597	0.08920607566202135
PIERSON SYNDROME	0.00387597	0.08920607566202135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.00387597	0.08920607566202135
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00387597	0.08920607566202135
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.00387597	0.08920607566202135
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.00387597	0.08920607566202135
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00387597	0.08920607566202135
ALPERS-HUTTENLOCHER SYNDROME	0.00387597	0.08920607566202135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.00387597	0.08920607566202135
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.00387597	0.08920607566202135
WIEACKER-WOLFF SYNDROME	0.00387597	0.08920607566202135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00387597	0.08920607566202135
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00387597	0.08920607566202135
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00387597	0.08920607566202135
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00387597	0.08920607566202135
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.00387597	0.08920607566202135
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00387597	0.08920607566202135
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00387597	0.08920607566202135
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	0.00387597	0.08920607566202135
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00387597	0.08920607566202135
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00387597	0.08920607566202135
MYOPATHY, CENTRONUCLEAR, 5	0.00387597	0.08920607566202135
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00387597	0.08920607566202135
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.00387597	0.08920607566202135
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00387597	0.08920607566202135
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00387597	0.08920607566202135
SPINOCEREBELLAR ATAXIA 1	0.00387597	0.08920607566202135
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.00387597	0.08920607566202135
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00387597	0.08920607566202135
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00387597	0.08920607566202135
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00387597	0.08920607566202135
RICHARDS-RUNDLE SYNDROME; RRNS	0.00387597	0.08920607566202135
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.00387597	0.08920607566202135
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.00387597	0.08920607566202135
OCULOPHARYNGODISTAL MYOPATHY	0.00387597	0.08920607566202135
GLYCOGEN STORAGE DISEASE II	0.00387597	0.08920607566202135
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00387597	0.08920607566202135
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.00387597	0.08920607566202135
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.00387597	0.08920607566202135
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.00387597	0.08920607566202135
RADICULONEUROPATHY, FATAL NEONATAL	0.00387597	0.08920607566202135
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00387597	0.08920607566202135
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00387597	0.08920607566202135
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00387597	0.08920607566202135
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00387597	0.08920607566202135
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.00387597	0.08920607566202135
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00387597	0.08920607566202135
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.00387597	0.08920607566202135
ALAGILLE SYNDROME 1; ALGS1	0.00387597	0.08920607566202135
PARAPARETIC VARIANT OF GUILLAIN-BARRÉ SYNDROME	0.00387597	0.08920607566202135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00384615	0.08851976354499219
LYMPHEDEMA, HEREDITARY, III	0.00384615	0.08851976354499219
611961 STEVENSON-CAREY SYNDROME	0.00384615	0.08851976354499219
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00384615	0.08851976354499219
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00384615	0.08851976354499219
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00384615	0.08851976354499219
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00384615	0.08851976354499219
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00384615	0.08851976354499219
MEIER-GORLIN SYNDROME 6; MGORS6	0.00384615	0.08851976354499219
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00384615	0.08851976354499219
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00384615	0.08851976354499219
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00384615	0.08851976354499219
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00384615	0.08851976354499219
POTOCKI-LUPSKI SYNDROME	0.00384615	0.08851976354499219
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00384615	0.08851976354499219
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00384615	0.08851976354499219
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00384615	0.08851976354499219
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00384615	0.08851976354499219
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.00384615	0.08851976354499219
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00384615	0.08851976354499219
22Q11.2 DELETION SYNDROME	0.00384615	0.08851976354499219
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00384615	0.08851976354499219
48,XXYY SYNDROME	0.00384615	0.08851976354499219
RETT SYNDROME, CONGENITAL VARIANT	0.00384615	0.08851976354499219
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.00384615	0.08851976354499219
AICARDI SYNDROME	0.00384615	0.08851976354499219
WEBB-DATTANI SYNDROME; WEDAS	0.00384615	0.08851976354499219
SCHAAF-YANG SYNDROME; SHFYNG	0.00384615	0.08851976354499219
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00384615	0.08851976354499219
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.00384615	0.08851976354499219
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00384615	0.08851976354499219
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00384615	0.08851976354499219
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00384615	0.08851976354499219
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00384615	0.08851976354499219
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.00384615	0.08851976354499219
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00384615	0.08851976354499219
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00384615	0.08851976354499219
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.00384615	0.08851976354499219
CARCINOMA OF ESOPHAGUS	0.00384615	0.08851976354499219
3C SYNDROME	0.00384615	0.08851976354499219
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00384615	0.08851976354499219
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.00384615	0.08851976354499219
COFFIN-SIRIS SYNDROME 6; CSS6	0.00384615	0.08851976354499219
MEIER-GORLIN SYNDROME 2; MGORS2	0.00384615	0.08851976354499219
8Q24.3 MICRODELETION SYNDROME	0.00384615	0.08851976354499219
CHOPS SYNDROME; CHOPS	0.00384615	0.08851976354499219
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00384615	0.08851976354499219
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.00384615	0.08851976354499219
X-LINKED EHLERS-DANLOS SYNDROME	0.00384615	0.08851976354499219
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00384615	0.08851976354499219
SWEENEY-COX SYNDROME; SWCOS	0.00384615	0.08851976354499219
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00384615	0.08851976354499219
MEIER-GORLIN SYNDROME 3; MGORS3	0.00384615	0.08851976354499219
MEIER-GORLIN SYNDROME 5; MGORS5	0.00384615	0.08851976354499219
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.00384615	0.08851976354499219
EOSINOPHILIC ESOPHAGITIS	0.00384615	0.08851976354499219
POPOV-CHANG SYNDROME; POPCHAS	0.00384615	0.08851976354499219
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00384615	0.08851976354499219
WIEDEMANN-STEINER SYNDROME	0.00384615	0.08851976354499219
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00384615	0.08851976354499219
KLEEFSTRA SYNDROME	0.00384615	0.08851976354499219
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00384615	0.08851976354499219
16P11.2P12.2 MICRODELETION SYNDROME	0.00384615	0.08851976354499219
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.00384615	0.08851976354499219
14Q12 MICRODELETION SYNDROME	0.00384615	0.08851976354499219
EMANUEL SYNDROME	0.00384615	0.08851976354499219
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00384615	0.08851976354499219
SLC35A2-CDG	0.00384615	0.08851976354499219
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00384615	0.08851976354499219
1Q21.1 MICRODUPLICATION SYNDROME	0.00384615	0.08851976354499219
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00384615	0.08851976354499219
HOLMES-GANG SYNDROME	0.00384615	0.08851976354499219
48,XXXY SYNDROME	0.00384615	0.08851976354499219
SHPRINTZEN-GOLDBERG SYNDROME	0.00384615	0.08851976354499219
FG SYNDROME TYPE 1	0.00384615	0.08851976354499219
INFANTILE DYSTONIA-PARKINSONISM	0.00384615	0.08851976354499219
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00384615	0.08851976354499219
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00384615	0.08851976354499219
FRAGILE X SYNDROME	0.00384615	0.08851976354499219
8Q12 MICRODUPLICATION SYNDROME	0.00384615	0.08851976354499219
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00384615	0.08851976354499219
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00384615	0.08851976354499219
16P13.11 MICRODELETION SYNDROME	0.00384615	0.08851976354499219
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00384615	0.08851976354499219
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00384615	0.08851976354499219
CORNELIA DE LANGE SYNDROME 1	0.00384615	0.08851976354499219
XQ28 (MECP2) DUPLICATION	0.00384615	0.08851976354499219
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00384615	0.08851976354499219
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.00384615	0.08851976354499219
TOWNES-BROCKS SYNDROME 1; TBS1	0.00384615	0.08851976354499219
GASTROESOPHAGEAL REFLUX	0.00384615	0.08851976354499219
BRANCHIOOCULOFACIAL SYNDROME	0.00384615	0.08851976354499219
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00384615	0.08851976354499219
COSTELLO SYNDROME	0.00384615	0.08851976354499219
DDOST-CDG	0.00384615	0.08851976354499219
CRI-DU-CHAT SYNDROME	0.00384615	0.08851976354499219
49,XXXXY SYNDROME	0.00384615	0.08851976354499219
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00384615	0.08851976354499219
ISOLATED POLYCYSTIC LIVER DISEASE	0.00384615	0.08851976354499219
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00384615	0.08851976354499219
PITT-HOPKINS SYNDROME	0.00384615	0.08851976354499219
PERIVENTRICULAR NODULAR HETEROTOPIA	0.00384615	0.08851976354499219
MEIER-GORLIN SYNDROME 1; MGORS1	0.00384615	0.08851976354499219
BOHRING-OPITZ SYNDROME	0.00384615	0.08851976354499219
OKAMOTO SYNDROME	0.00384615	0.08851976354499219
NK-CELL ENTEROPATHY	0.00384615	0.08851976354499219
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00384615	0.08851976354499219
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00384615	0.08851976354499219
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.00384615	0.08851976354499219
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00384615	0.08851976354499219
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00384615	0.08851976354499219
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00384615	0.08851976354499219
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00384615	0.08851976354499219
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00384615	0.08851976354499219
CHRISTIANSON SYNDROME	0.00384615	0.08851976354499219
MIRAGE SYNDROME; MIRAGE	0.00384615	0.08851976354499219
GENITOPATELLAR SYNDROME	0.00384615	0.08851976354499219
17P11.2 MICRODUPLICATION SYNDROME	0.00384615	0.08851976354499219
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00384615	0.08851976354499219
BOHRING-OPITZ SYNDROME	0.00384615	0.08851976354499219
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00384615	0.08851976354499219
SILVER-RUSSELL SYNDROME	0.00384615	0.08851976354499219
SMITH-LEMLI-OPITZ SYNDROME	0.00384615	0.08851976354499219
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00384615	0.08851976354499219
STICKLER SYNDROME	0.00384615	0.08851976354499219
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00384615	0.08851976354499219
CANAVAN DISEASE	0.00384615	0.08851976354499219
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.00384615	0.08851976354499219
IDIOPATHIC PULMONARY FIBROSIS	0.00384615	0.08851976354499219
FRYNS SYNDROME	0.00384615	0.08851976354499219
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00384615	0.08851976354499219
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00384615	0.08851976354499219
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00384615	0.08851976354499219
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00384615	0.08851976354499219
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00384615	0.08851976354499219
RETT SYNDROME; RTT	0.00384615	0.08851976354499219
FOCAL DERMAL HYPOPLASIA	0.00384615	0.08851976354499219
CODAS SYNDROME	0.00384615	0.08851976354499219
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00384615	0.08851976354499219
EMANUEL SYNDROME	0.00384615	0.08851976354499219
FOLLICULAR LYMPHOMA	0.0035461	0.08161406432585751
PRIMARY MYELOFIBROSIS	0.0035461	0.08161406432585751
LYMPHANGIOLEIOMYOMATOSIS	0.0035461	0.08161406432585751
HERMANSKY-PUDLAK SYNDROME	0.0035461	0.08161406432585751
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0035461	0.08161406432585751
ADIPOSIS DOLOROSA	0.0035461	0.08161406432585751
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.0035461	0.08161406432585751
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0035461	0.08161406432585751
ANISOCORIA	0.0035461	0.08161406432585751
THYMOMA	0.0035461	0.08161406432585751
THYMIC CARCINOMA	0.0035461	0.08161406432585751
REFRACTORY ANEMIA	0.0035461	0.08161406432585751
PERIPARTUM CARDIOMYOPATHY	0.0035461	0.08161406432585751
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.08161406432585751
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0035461	0.08161406432585751
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0035461	0.08161406432585751
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0035461	0.08161406432585751
CHOLANGIOCARCINOMA	0.0035461	0.08161406432585751
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0035461	0.08161406432585751
PANHYPOPITUITARISM	0.0035461	0.08161406432585751
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.0035461	0.08161406432585751
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.0035461	0.08161406432585751
MAST CELL SARCOMA	0.0035461	0.08161406432585751
SATOYOSHI SYNDROME	0.0035461	0.08161406432585751
NON-FUNCTIONING PARAGANGLIOMA	0.0035461	0.08161406432585751
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.0035461	0.08161406432585751
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.08161406432585751
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.0035461	0.08161406432585751
CONGENITAL ANALBUMINEMIA	0.0035461	0.08161406432585751
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0035461	0.08161406432585751
POST-TRAUMATIC PITUITARY DEFICIENCY	0.0035461	0.08161406432585751
FAMILIAL THYROID DYSHORMONOGENESIS	0.0035461	0.08161406432585751
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0035461	0.08161406432585751
THYROID HEMIAGENESIS	0.0035461	0.08161406432585751
THYROID HYPOPLASIA	0.0035461	0.08161406432585751
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.08161406432585751
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0035461	0.08161406432585751
ACROMEGALY	0.0035461	0.08161406432585751
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0035461	0.08161406432585751
HEMOCHROMATOSIS, TYPE 4; HFE4	0.0035461	0.08161406432585751
ADULT-ONSET STILL DISEASE	0.0035461	0.08161406432585751
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.0035461	0.08161406432585751
KLATSKIN TUMOR	0.0035461	0.08161406432585751
KUFOR-RAKEB SYNDROME	0.0035461	0.08161406432585751
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0035461	0.08161406432585751
KIKUCHI-FUJIMOTO DISEASE	0.0035461	0.08161406432585751
X-LINKED AGAMMAGLOBULINEMIA	0.0035461	0.08161406432585751
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.0035461	0.08161406432585751
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.08161406432585751
INSULIN-RESISTANCE SYNDROME TYPE B	0.0035461	0.08161406432585751
ISOLATED AGAMMAGLOBULINEMIA	0.0035461	0.08161406432585751
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0035461	0.08161406432585751
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.0035461	0.08161406432585751
HEMORRHAGIC FEVER-RENAL SYNDROME	0.0035461	0.08161406432585751
PERIPHERAL HYPOTHYROIDISM	0.0035461	0.08161406432585751
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0035461	0.08161406432585751
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0035461	0.08161406432585751
BLACKFAN-DIAMOND ANEMIA	0.0035461	0.08161406432585751
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.0035461	0.08161406432585751
PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.08161406432585751
AREGENERATIVE ANEMIA	0.0035461	0.08161406432585751
THYMIC EPITHELIAL NEOPLASM	0.0035461	0.08161406432585751
TUBERCULOSIS	0.0035461	0.08161406432585751
CRONKHITE-CANADA SYNDROME	0.0035461	0.08161406432585751
MULTIPLE MYELOMA	0.0035461	0.08161406432585751
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0035461	0.08161406432585751
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.0035461	0.08161406432585751
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.0035461	0.08161406432585751
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0035461	0.08161406432585751
HYPOTONIA-CYSTINURIA SYNDROME	0.0035461	0.08161406432585751
GAUCHER DISEASE	0.0035461	0.08161406432585751
ACUTE MONOBLASTIC LEUKEMIA	0.0035461	0.08161406432585751
MANTLE CELL LYMPHOMA	0.0035461	0.08161406432585751
EBSTEIN MALFORMATION	0.0035461	0.08161406432585751
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0035461	0.08161406432585751
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0035461	0.08161406432585751
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0035461	0.08161406432585751
EOSINOPHILIC FASCIITIS	0.0035461	0.08161406432585751
DUBIN-JOHNSON SYNDROME	0.0035461	0.08161406432585751
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0035461	0.08161406432585751
SOMATOMAMMOTROPINOMA	0.0035461	0.08161406432585751
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0035461	0.08161406432585751
CYCLIC NEUTROPENIA	0.0035461	0.08161406432585751
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0035461	0.08161406432585751
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0035461	0.08161406432585751
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.0035461	0.08161406432585751
CHRONIC MYELOID LEUKEMIA	0.0035461	0.08161406432585751
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.08161406432585751
TETRASOMY 9P	0.0035461	0.08161406432585751
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00344828	0.0793627212243219
TRISOMY XQ28	0.00344828	0.0793627212243219
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.00344828	0.0793627212243219
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.0793627212243219
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.0793627212243219
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.0793627212243219
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00344828	0.0793627212243219
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.00344828	0.0793627212243219
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00344828	0.0793627212243219
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.0793627212243219
ALZHEIMER DISEASE 3; AD	0.00344828	0.0793627212243219
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.0793627212243219
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.0793627212243219
ATAXIA-TELANGIECTASIA	0.00344828	0.0793627212243219
THORACOMELIC DYSPLASIA	0.00344828	0.0793627212243219
FRIED SYNDROME	0.00344828	0.0793627212243219
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00344828	0.0793627212243219
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.0793627212243219
BRITTLE CORNEA SYNDROME 2; BCS2	0.00344828	0.0793627212243219
PSEUDOACHONDROPLASIA	0.00344828	0.0793627212243219
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.00344828	0.0793627212243219
JOUBERT SYNDROME	0.00344828	0.0793627212243219
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.0793627212243219
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.0793627212243219
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.0793627212243219
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00344828	0.0793627212243219
SPINOCEREBELLAR ATAXIA TYPE 17	0.00344828	0.0793627212243219
OROFACIODIGITAL SYNDROME TYPE 6	0.00344828	0.0793627212243219
HYDROCEPHALUS, NORMAL-PRESSURE	0.00344828	0.0793627212243219
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00344828	0.0793627212243219
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.0793627212243219
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00344828	0.0793627212243219
FREE SIALIC ACID STORAGE DISEASE	0.00344828	0.0793627212243219
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.00344828	0.0793627212243219
NON-DISTAL MONOSOMY 10Q	0.00344828	0.0793627212243219
NEUROFERRITINOPATHY	0.00344828	0.0793627212243219
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00344828	0.0793627212243219
KUFOR-RAKEB SYNDROME	0.00344828	0.0793627212243219
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.0793627212243219
SHWACHMAN-DIAMOND SYNDROME	0.00344828	0.0793627212243219
RICHARDS-RUNDLE SYNDROME	0.00344828	0.0793627212243219
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00344828	0.0793627212243219
BENIGN HEREDITARY CHOREA	0.00344828	0.0793627212243219
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.0793627212243219
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.0793627212243219
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.0793627212243219
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00344828	0.0793627212243219
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00344828	0.0793627212243219
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.00344828	0.0793627212243219
OSTEOCHONDRITIS DISSECANS	0.00344828	0.0793627212243219
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00344828	0.0793627212243219
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.0793627212243219
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00344828	0.0793627212243219
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00344828	0.0793627212243219
CORTICOBASAL SYNDROME	0.00344828	0.0793627212243219
DOWN SYNDROME	0.00344828	0.0793627212243219
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.0793627212243219
DYSTONIA 16; DYT16	0.00344828	0.0793627212243219
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.0793627212243219
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.0793627212243219
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00344828	0.0793627212243219
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00344828	0.0793627212243219
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.0793627212243219
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.0793627212243219
DYSTONIA 23; DYT23	0.00344828	0.0793627212243219
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00344828	0.0793627212243219
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.0793627212243219
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.0793627212243219
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.0793627212243219
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00344828	0.0793627212243219
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.0793627212243219
PARTINGTON SYNDROME	0.00344828	0.0793627212243219
MELNICK-NEEDLES SYNDROME	0.00344828	0.0793627212243219
COHEN-GIBSON SYNDROME; COGIS	0.00344828	0.0793627212243219
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00344828	0.0793627212243219
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.0793627212243219
MASA SYNDROME	0.00344828	0.0793627212243219
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00344828	0.0793627212243219
MUCOLIPIDOSIS TYPE IV	0.00344828	0.0793627212243219
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.0793627212243219
LERI PLEONOSTEOSIS	0.00344828	0.0793627212243219
JOUBERT SYNDROME 24	0.00344828	0.0793627212243219
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.0793627212243219
NIEMANN-PICK DISEASE TYPE C	0.00344828	0.0793627212243219
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.0793627212243219
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.0793627212243219
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00344828	0.0793627212243219
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.0793627212243219
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00344828	0.0793627212243219
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00344828	0.0793627212243219
JOUBERT SYNDROME WITH RENAL DEFECT	0.00344828	0.0793627212243219
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.0793627212243219
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.00344828	0.0793627212243219
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.0793627212243219
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.0793627212243219
ABETA AMYLOIDOSIS, IOWA TYPE	0.00344828	0.0793627212243219
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.0793627212243219
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.0793627212243219
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00344828	0.0793627212243219
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.0793627212243219
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00344828	0.0793627212243219
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.0793627212243219
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00344828	0.0793627212243219
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.00344828	0.0793627212243219
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.0793627212243219
PRIMARY DYSTONIA, DYT4 TYPE	0.00344828	0.0793627212243219
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.0793627212243219
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.0793627212243219
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00344828	0.0793627212243219
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.00344828	0.0793627212243219
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.00344828	0.0793627212243219
FOIX-CHAVANY-MARIE SYNDROME	0.00344828	0.0793627212243219
TETRASOMY 18P	0.00344828	0.0793627212243219
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00344828	0.0793627212243219
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.0793627212243219
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.0793627212243219
FILIPPI SYNDROME; FLPIS	0.00316456	0.07283285959308412
SCHINZEL-GIEDION SYNDROME	0.00316456	0.07283285959308412
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.07283285959308412
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.07283285959308412
SPASTIC PARAPLEGIA 16, X-LINKED	0.00316456	0.07283285959308412
ALBINISM, OCULAR, TYPE I	0.00316456	0.07283285959308412
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00316456	0.07283285959308412
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.07283285959308412
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00316456	0.07283285959308412
16Q24.3 MICRODELETION SYNDROME	0.00316456	0.07283285959308412
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00316456	0.07283285959308412
CRANIOTELENCEPHALIC DYSPLASIA	0.00316456	0.07283285959308412
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00316456	0.07283285959308412
FUMARASE DEFICIENCY; FMRD	0.00316456	0.07283285959308412
INFANTILE NEUROAXONAL DYSTROPHY	0.00316456	0.07283285959308412
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.07283285959308412
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00316456	0.07283285959308412
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.07283285959308412
BLUE CONE MONOCHROMATISM	0.00316456	0.07283285959308412
N SYNDROME	0.00316456	0.07283285959308412
ACRODERMATITIS ENTEROPATHICA	0.00316456	0.07283285959308412
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.07283285959308412
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.00316456	0.07283285959308412
CHROMOSOME XP11.3 DELETION SYNDROME	0.00316456	0.07283285959308412
GAPO SYNDROME	0.00316456	0.07283285959308412
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00316456	0.07283285959308412
MUCOLIPIDOSIS IV; ML4	0.00316456	0.07283285959308412
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.07283285959308412
WAGR SYNDROME	0.00316456	0.07283285959308412
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.07283285959308412
INTESTINAL LYMPHANGIECTASIA	0.00316456	0.07283285959308412
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00316456	0.07283285959308412
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00316456	0.07283285959308412
PRADER-WILLI-LIKE SYNDROME	0.00316456	0.07283285959308412
CONGENITAL TOXOPLASMOSIS	0.00316456	0.07283285959308412
TREACHER-COLLINS SYNDROME	0.00316456	0.07283285959308412
CONE ROD DYSTROPHY	0.00316456	0.07283285959308412
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.07283285959308412
JALILI SYNDROME	0.00316456	0.07283285959308412
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.07283285959308412
HYPERTRYPTOPHANEMIA; HYPTRP	0.00316456	0.07283285959308412
TRIPLE A SYNDROME	0.00316456	0.07283285959308412
FETAL METHYLMERCURY SYNDROME	0.00316456	0.07283285959308412
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00316456	0.07283285959308412
X-LINKED RETINAL DYSPLASIA	0.00316456	0.07283285959308412
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.00316456	0.07283285959308412
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00316456	0.07283285959308412
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.07283285959308412
GOLDENHAR SYNDROME	0.00316456	0.07283285959308412
FANCONI ANEMIA	0.00316456	0.07283285959308412
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.07283285959308412
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.07283285959308412
ACRO-RENAL-OCULAR SYNDROME	0.00316456	0.07283285959308412
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00316456	0.07283285959308412
APERT SYNDROME	0.00316456	0.07283285959308412
RFT1-CDG	0.00316456	0.07283285959308412
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00316456	0.07283285959308412
HALLERMANN-STREIFF SYNDROME	0.00316456	0.07283285959308412
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.07283285959308412
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.07283285959308412
BLUE CONE MONOCHROMACY; BCM	0.00316456	0.07283285959308412
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.00316456	0.07283285959308412
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00316456	0.07283285959308412
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00316456	0.07283285959308412
LOWRY-WOOD SYNDROME	0.00316456	0.07283285959308412
N SYNDROME	0.00316456	0.07283285959308412
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00316456	0.07283285959308412
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.07283285959308412
ABLEPHARON MACROSTOMIA SYNDROME	0.00316456	0.07283285959308412
BROOKE-SPIEGLER SYNDROME	0.00316456	0.07283285959308412
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00316456	0.07283285959308412
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00316456	0.07283285959308412
MOEBIUS SYNDROME	0.00316456	0.07283285959308412
MICROPHTHALMIA, LENZ TYPE	0.00316456	0.07283285959308412
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00316456	0.07283285959308412
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.07283285959308412
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00316456	0.07283285959308412
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00316456	0.07283285959308412
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00316456	0.07283285959308412
CONE-ROD DYSTROPHY 17; CORD17	0.00316456	0.07283285959308412
GILLESPIE SYNDROME; GLSP	0.00316456	0.07283285959308412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00316456	0.07283285959308412
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.07283285959308412
OCULAR ALBINISM	0.00316456	0.07283285959308412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00316456	0.07283285959308412
RENAL COLOBOMA SYNDROME	0.00316456	0.07283285959308412
FOUNTAIN SYNDROME	0.00316456	0.07283285959308412
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00316456	0.07283285959308412
PETERS PLUS SYNDROME	0.00316456	0.07283285959308412
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00316456	0.07283285959308412
OCULOCUTANEOUS ALBINISM	0.00316456	0.07283285959308412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00316456	0.07283285959308412
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00316456	0.07283285959308412
COFFIN-SIRIS SYNDROME 4; CSS4	0.00316456	0.07283285959308412
COFFIN-SIRIS SYNDROME 3; CSS3	0.00316456	0.07283285959308412
COFFIN-SIRIS SYNDROME 2; CSS2	0.00316456	0.07283285959308412
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.00316456	0.07283285959308412
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00316456	0.07283285959308412
JABERI-ELAHI SYNDROME; JABELS	0.00316456	0.07283285959308412
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.07283285959308412
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.07283285959308412
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.07283285959308412
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.07283285959308412
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00316456	0.07283285959308412
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.07283285959308412
CREUTZFELDT-JAKOB DISEASE; CJD	0.00316456	0.07283285959308412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00316456	0.07283285959308412
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00316456	0.07283285959308412
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.00316456	0.07283285959308412
COFFIN-SIRIS SYNDROME 1; CSS1	0.00316456	0.07283285959308412
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.07283285959308412
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00316456	0.07283285959308412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00316456	0.07283285959308412
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00316456	0.07283285959308412
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00316456	0.07283285959308412
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00316456	0.07283285959308412
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00316456	0.07283285959308412
HELSMOORTEL-VAN DER AA SYNDROME	0.00316456	0.07283285959308412
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.07283285959308412
CONGENITAL RUBELLA SYNDROME	0.00316456	0.07283285959308412
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.07283285959308412
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00316456	0.07283285959308412
MULTIPLE SULFATASE DEFICIENCY	0.00316456	0.07283285959308412
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00316456	0.07283285959308412
CROUZON SYNDROME	0.00316456	0.07283285959308412
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00316456	0.07283285959308412
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00316456	0.07283285959308412
BUSCHKE-OLLENDORFF SYNDROME	0.00316456	0.07283285959308412
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00316456	0.07283285959308412
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.07283285959308412
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.07283285959308412
MMEP SYNDROME	0.00316456	0.07283285959308412
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00316456	0.07283285959308412
FISH-EYE DISEASE	0.00316456	0.07283285959308412
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00316456	0.07283285959308412
ASCHER SYNDROME	0.00316456	0.07283285959308412
BONNEMANN-MEINECKE-REICH SYNDROME	0.00316456	0.07283285959308412
AYMÉ-GRIPP SYNDROME	0.00316456	0.07283285959308412
VOGT-KOYANAGI-HARADA DISEASE	0.00316456	0.07283285959308412
UNILATERAL POLYMICROGYRIA	0.00316456	0.07283285959308412
NEONATAL ADRENOLEUKODYSTROPHY	0.00316456	0.07283285959308412
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00316456	0.07283285959308412
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00316456	0.07283285959308412
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.07283285959308412
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.07283285959308412
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.07283285959308412
OCULOCUTANEOUS ALBINISM TYPE 2	0.00316456	0.07283285959308412
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00316456	0.07283285959308412
OCULOCUTANEOUS ALBINISM TYPE 4	0.00316456	0.07283285959308412
JOUBERT SYNDROME 3; JBTS3	0.00316456	0.07283285959308412
JOUBERT SYNDROME 2	0.00316456	0.07283285959308412
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.07283285959308412
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.00316456	0.07283285959308412
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00316456	0.07283285959308412
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.07283285959308412
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00316456	0.07283285959308412
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00316456	0.07283285959308412
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.07283285959308412
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00316456	0.07283285959308412
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00316456	0.07283285959308412
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00316456	0.07283285959308412
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00316456	0.07283285959308412
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00316456	0.07283285959308412
RETINITIS PIGMENTOSA 20	0.00316456	0.07283285959308412
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00316456	0.07283285959308412
BRADYOPSIA	0.00316456	0.07283285959308412
RETINITIS PIGMENTOSA 27; RP27	0.00316456	0.07283285959308412
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00316456	0.07283285959308412
COHEN SYNDROME	0.00316456	0.07283285959308412
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.07283285959308412
PSEUDOXANTHOMA ELASTICUM	0.00316456	0.07283285959308412
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.07283285959308412
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.07283285959308412
PAPILLOMA OF CHOROID PLEXUS	0.00316456	0.07283285959308412
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00316456	0.07283285959308412
CONE DYSTROPHY 4	0.00316456	0.07283285959308412
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00316456	0.07283285959308412
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.07283285959308412
X-LINKED RECESSIVE OCULAR ALBINISM	0.00316456	0.07283285959308412
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.07283285959308412
PROLIDASE DEFICIENCY	0.00316456	0.07283285959308412
ADIE PUPIL	0.00308642	0.07103445487059393
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00308642	0.07103445487059393
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00308642	0.07103445487059393
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00308642	0.07103445487059393
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00308642	0.07103445487059393
NON-DISTAL MONOSOMY 20Q	0.00308642	0.07103445487059393
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00308642	0.07103445487059393
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA TYPE 1	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA TYPE 2	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA TYPE 10	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00308642	0.07103445487059393
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00308642	0.07103445487059393
HOYERAAL-HREIDARSSON SYNDROME	0.00308642	0.07103445487059393
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00308642	0.07103445487059393
NEONATAL MARFAN SYNDROME	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00308642	0.07103445487059393
SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANTSPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED	0.00308642	0.07103445487059393
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00308642	0.07103445487059393
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00308642	0.07103445487059393
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.00308642	0.07103445487059393
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00308642	0.07103445487059393
REFSUM DISEASE	0.00308642	0.07103445487059393
FACIAL SPASM	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00308642	0.07103445487059393
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00308642	0.07103445487059393
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00308642	0.07103445487059393
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.00308642	0.07103445487059393
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00308642	0.07103445487059393
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00308642	0.07103445487059393
PERRAULT SYNDROME 5; PRLTS5	0.00308642	0.07103445487059393
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.00308642	0.07103445487059393
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.00308642	0.07103445487059393
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00308642	0.07103445487059393
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00308642	0.07103445487059393
GLYCINE ENCEPHALOPATHY; GCE	0.00308642	0.07103445487059393
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00308642	0.07103445487059393
LOEYS-DIETZ SYNDROME 5	0.00308642	0.07103445487059393
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00308642	0.07103445487059393
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00308642	0.07103445487059393
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00308642	0.07103445487059393
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00308642	0.07103445487059393
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.00308642	0.07103445487059393
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00308642	0.07103445487059393
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00308642	0.07103445487059393
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.00308642	0.07103445487059393
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.00308642	0.07103445487059393
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.00308642	0.07103445487059393
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00308642	0.07103445487059393
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00308642	0.07103445487059393
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00308642	0.07103445487059393
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.00308642	0.07103445487059393
IMMUNODEFICIENCY 23; IMD23	0.00308642	0.07103445487059393
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00308642	0.07103445487059393
VERVERI-BRADY SYNDROME; VERBRAS	0.00308642	0.07103445487059393
NEMALINE MYOPATHY 4	0.00308642	0.07103445487059393
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00308642	0.07103445487059393
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00308642	0.07103445487059393
HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	0.00308642	0.07103445487059393
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00308642	0.07103445487059393
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.00308642	0.07103445487059393
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00308642	0.07103445487059393
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00308642	0.07103445487059393
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00308642	0.07103445487059393
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00308642	0.07103445487059393
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00308642	0.07103445487059393
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00308642	0.07103445487059393
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00308642	0.07103445487059393
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00308642	0.07103445487059393
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.00308642	0.07103445487059393
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA TYPE 31	0.00308642	0.07103445487059393
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00308642	0.07103445487059393
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00308642	0.07103445487059393
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00308642	0.07103445487059393
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00308642	0.07103445487059393
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00308642	0.07103445487059393
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.00308642	0.07103445487059393
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00308642	0.07103445487059393
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00308642	0.07103445487059393
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00308642	0.07103445487059393
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.00308642	0.07103445487059393
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.00308642	0.07103445487059393
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00308642	0.07103445487059393
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00308642	0.07103445487059393
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.00308642	0.07103445487059393
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.00308642	0.07103445487059393
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.00308642	0.07103445487059393
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	0.00308642	0.07103445487059393
CHROMOSOME 2Q37 DELETION SYNDROME	0.00308642	0.07103445487059393
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00308642	0.07103445487059393
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V	0.00308642	0.07103445487059393
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00308642	0.07103445487059393
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00308642	0.07103445487059393
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00308642	0.07103445487059393
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00308642	0.07103445487059393
PELIZAEUS-MERZBACHER DISEASE	0.00308642	0.07103445487059393
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.00308642	0.07103445487059393
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00294985	0.06789127425950502
FOCAL MYOSITIS	0.00294985	0.06789127425950502
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00294985	0.06789127425950502
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.00294985	0.06789127425950502
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00294985	0.06789127425950502
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00294985	0.06789127425950502
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00294985	0.06789127425950502
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00294985	0.06789127425950502
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00294985	0.06789127425950502
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00294985	0.06789127425950502
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.00294985	0.06789127425950502
AMYOTROPHIC LATERAL SCLEROSIS 1	0.00294985	0.06789127425950502
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.00294985	0.06789127425950502
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.00294985	0.06789127425950502
MULTIPLE OSTEOCHONDROMAS	0.00294985	0.06789127425950502
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00294985	0.06789127425950502
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.00294985	0.06789127425950502
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00294985	0.06789127425950502
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00294985	0.06789127425950502
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00294985	0.06789127425950502
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.00294985	0.06789127425950502
159100 MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE	0.00294985	0.06789127425950502
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00294985	0.06789127425950502
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00294985	0.06789127425950502
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00294985	0.06789127425950502
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00294985	0.06789127425950502
EPISODIC ATAXIA, TYPE 8	0.00294985	0.06789127425950502
SPASTIC PARAPLEGIA TYPE 2	0.00294985	0.06789127425950502
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.00294985	0.06789127425950502
NIJMEGEN BREAKAGE SYNDROME	0.00294985	0.06789127425950502
NOONAN SYNDROME	0.00294985	0.06789127425950502
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES	0.00294985	0.06789127425950502
SUPRABULBAR PARESIS, CONGENITAL	0.00294985	0.06789127425950502
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00294985	0.06789127425950502
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00294985	0.06789127425950502
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00294985	0.06789127425950502
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00294985	0.06789127425950502
ISAAC SYNDROME	0.00294985	0.06789127425950502
BETA-THALASSEMIA	0.00294985	0.06789127425950502
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00294985	0.06789127425950502
THYROID ECTOPIA	0.00294985	0.06789127425950502
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00294985	0.06789127425950502
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00294985	0.06789127425950502
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00294985	0.06789127425950502
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00294985	0.06789127425950502
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.00294985	0.06789127425950502
MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION	0.00294985	0.06789127425950502
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.00294985	0.06789127425950502
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00294985	0.06789127425950502
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00294985	0.06789127425950502
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00294985	0.06789127425950502
KEARNS-SAYRE SYNDROME; KSS	0.00294985	0.06789127425950502
COWCHOCK SYNDROME; COWCK	0.00294985	0.06789127425950502
JUVENILE PRIMARY LATERAL SCLEROSIS	0.00294985	0.06789127425950502
GLYCOGEN STORAGE DISEASE IXB	0.00294985	0.06789127425950502
CUTIS LAXA	0.00294985	0.06789127425950502
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00294985	0.06789127425950502
EPISODIC ATAXIA TYPE 7	0.00294985	0.06789127425950502
PYLE DISEASE; PYL	0.00294985	0.06789127425950502
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00294985	0.06789127425950502
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00294985	0.06789127425950502
MUSCLE GLYCOGENOSIS, X-LINKED	0.00294985	0.06789127425950502
%300211 EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX	0.00294985	0.06789127425950502
CRYOGLOBULINEMIC VASCULITIS	0.00294985	0.06789127425950502
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00294985	0.06789127425950502
SPONDYLOOCULAR SYNDROME; SOS	0.00294985	0.06789127425950502
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00294985	0.06789127425950502
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00294985	0.06789127425950502
GLYCOGEN STORAGE DISEASE V; GSD5	0.00294985	0.06789127425950502
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00294985	0.06789127425950502
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00294985	0.06789127425950502
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00294985	0.06789127425950502
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00294985	0.06789127425950502
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00294985	0.06789127425950502
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00294985	0.06789127425950502
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00294985	0.06789127425950502
STIFF SKIN SYNDROME	0.00294985	0.06789127425950502
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00294985	0.06789127425950502
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00294985	0.06789127425950502
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00294985	0.06789127425950502
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00294985	0.06789127425950502
RETT SYNDROME	0.00294985	0.06789127425950502
GLYCOGEN STORAGE DISEASE VII	0.00294985	0.06789127425950502
HEREDITARY SPHEROCYTOSIS	0.00294985	0.06789127425950502
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00294985	0.06789127425950502
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.00294985	0.06789127425950502
EPISODIC ATAXIA, TYPE 7; EA7	0.00294985	0.06789127425950502
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00294985	0.06789127425950502
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00294985	0.06789127425950502
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00294985	0.06789127425950502
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00294985	0.06789127425950502
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00294985	0.06789127425950502
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.00294985	0.06789127425950502
NAKAJO-NISHIMURA SYNDROME	0.00294985	0.06789127425950502
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00294985	0.06789127425950502
ADRENOCORTICAL CARCINOMA	0.00294985	0.06789127425950502
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00294985	0.06789127425950502
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00294985	0.06789127425950502
